
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory Regions - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="DB2B3E08926530C33C3E080001009E4B.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="ijms">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8305371/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="International Journal of Molecular Sciences">
<meta name="citation_title" content="Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory Regions">
<meta name="citation_author" content="Chiara Guglielmi">
<meta name="citation_author_institution" content="SOD Molecular Genetics, University Hospital of Pisa, 56126 Pisa, Italy; chiara.guglielmi.cg@gmail.com (C.G.); eleonoraconti4@gmail.com (E.C.); mariella.tancredi@gmail.com (M.T.); cunegonda_f@yahoo.it (E.F.); c.cosini@ao-pisa.toscana.it (C.C.)">
<meta name="citation_author" content="Rosa Scarpitta">
<meta name="citation_author_institution" content="Division of Pathology, University of Pisa, 56126 Pisa, Italy; rose2312@hotmail.it">
<meta name="citation_author" content="Gaetana Gambino">
<meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy; gaetana.gambino@gmail.com">
<meta name="citation_author" content="Eleonora Conti">
<meta name="citation_author_institution" content="SOD Molecular Genetics, University Hospital of Pisa, 56126 Pisa, Italy; chiara.guglielmi.cg@gmail.com (C.G.); eleonoraconti4@gmail.com (E.C.); mariella.tancredi@gmail.com (M.T.); cunegonda_f@yahoo.it (E.F.); c.cosini@ao-pisa.toscana.it (C.C.)">
<meta name="citation_author" content="Francesca Bellè">
<meta name="citation_author_institution" content="Functional Genetics and Genomics Laboratory, Institute of Clinical Physiology, IFC-CNR, 56127 Pisa, Italy; f.belle01@hotmail.com (F.B.); tizicerv@ifc.cnr.it (T.C.)">
<meta name="citation_author" content="Mariella Tancredi">
<meta name="citation_author_institution" content="SOD Molecular Genetics, University Hospital of Pisa, 56126 Pisa, Italy; chiara.guglielmi.cg@gmail.com (C.G.); eleonoraconti4@gmail.com (E.C.); mariella.tancredi@gmail.com (M.T.); cunegonda_f@yahoo.it (E.F.); c.cosini@ao-pisa.toscana.it (C.C.)">
<meta name="citation_author" content="Tiziana Cervelli">
<meta name="citation_author_institution" content="Functional Genetics and Genomics Laboratory, Institute of Clinical Physiology, IFC-CNR, 56127 Pisa, Italy; f.belle01@hotmail.com (F.B.); tizicerv@ifc.cnr.it (T.C.)">
<meta name="citation_author" content="Elisabetta Falaschi">
<meta name="citation_author_institution" content="SOD Molecular Genetics, University Hospital of Pisa, 56126 Pisa, Italy; chiara.guglielmi.cg@gmail.com (C.G.); eleonoraconti4@gmail.com (E.C.); mariella.tancredi@gmail.com (M.T.); cunegonda_f@yahoo.it (E.F.); c.cosini@ao-pisa.toscana.it (C.C.)">
<meta name="citation_author" content="Cinzia Cosini">
<meta name="citation_author_institution" content="SOD Molecular Genetics, University Hospital of Pisa, 56126 Pisa, Italy; chiara.guglielmi.cg@gmail.com (C.G.); eleonoraconti4@gmail.com (E.C.); mariella.tancredi@gmail.com (M.T.); cunegonda_f@yahoo.it (E.F.); c.cosini@ao-pisa.toscana.it (C.C.)">
<meta name="citation_author" content="Paolo Aretini">
<meta name="citation_author_institution" content="Section of Oncological Genomics, Fondazione Pisana per la Scienza, 56017 Pisa, Italy; p.aretini@fpscience.it">
<meta name="citation_author" content="Caterina Congregati">
<meta name="citation_author_institution" content="Division of Internal Medicine, University Hospital of Pisa, 56126 Pisa, Italy; c.congregati@ao-pisa.toscana.it">
<meta name="citation_author" content="Marco Marino">
<meta name="citation_author_institution" content="Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy; marcomarino83@gmail.com (M.M.); elena.tenedini@unimore.it (E.T.); enrico.tagliafico@unimore.it (E.T.)">
<meta name="citation_author" content="Margherita Patruno">
<meta name="citation_author_institution" content="IRCCS Istituto Tumori “Giovanni Paolo II”, 70124 Bari, Italy; m.patruno@oncologico.bari.it (M.P.); brunellapilato@gmail.com (B.P.); s.tommasi@oncologico.bari.it (S.T.)">
<meta name="citation_author" content="Brunella Pilato">
<meta name="citation_author_institution" content="IRCCS Istituto Tumori “Giovanni Paolo II”, 70124 Bari, Italy; m.patruno@oncologico.bari.it (M.P.); brunellapilato@gmail.com (B.P.); s.tommasi@oncologico.bari.it (S.T.)">
<meta name="citation_author" content="Francesca Spina">
<meta name="citation_author_institution" content="SC Medical Genetics, ASSL Cagliari, 09126 Cagliari, Italy; francescaspina@hotmail.com (F.S.); luibale@hotmail.com (L.B.); cateviva@libero.it (C.V.)">
<meta name="citation_author" content="Luisa Balestrino">
<meta name="citation_author_institution" content="SC Medical Genetics, ASSL Cagliari, 09126 Cagliari, Italy; francescaspina@hotmail.com (F.S.); luibale@hotmail.com (L.B.); cateviva@libero.it (C.V.)">
<meta name="citation_author" content="Elena Tenedini">
<meta name="citation_author_institution" content="Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy; marcomarino83@gmail.com (M.M.); elena.tenedini@unimore.it (E.T.); enrico.tagliafico@unimore.it (E.T.)">
<meta name="citation_author" content="Ileana Carnevali">
<meta name="citation_author_institution" content="Ospedale di Circolo ASST Settelaghi, 21100 Varese, Italy; ileana.carnevali@asst-settelaghi.it (I.C.); mariagrazia.tibiletti@asst-settelaghi.it (M.G.T.)">
<meta name="citation_author" content="Laura Cortesi">
<meta name="citation_author_institution" content="Department of Oncology, Haematology and Respiratory Diseases, University Hospital of Modena, 41124 Modena, Italy; cortesilaura67@gmail.com">
<meta name="citation_author" content="Enrico Tagliafico">
<meta name="citation_author_institution" content="Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy; marcomarino83@gmail.com (M.M.); elena.tenedini@unimore.it (E.T.); enrico.tagliafico@unimore.it (E.T.)">
<meta name="citation_author" content="Maria Grazia Tibiletti">
<meta name="citation_author_institution" content="Ospedale di Circolo ASST Settelaghi, 21100 Varese, Italy; ileana.carnevali@asst-settelaghi.it (I.C.); mariagrazia.tibiletti@asst-settelaghi.it (M.G.T.)">
<meta name="citation_author" content="Stefania Tommasi">
<meta name="citation_author_institution" content="IRCCS Istituto Tumori “Giovanni Paolo II”, 70124 Bari, Italy; m.patruno@oncologico.bari.it (M.P.); brunellapilato@gmail.com (B.P.); s.tommasi@oncologico.bari.it (S.T.)">
<meta name="citation_author" content="Matteo Ghilli">
<meta name="citation_author_institution" content="Breast Cancer Center, University Hospital, 56126 Pisa, Italy; m.ghilli@ao-pisa.toscana.it">
<meta name="citation_author" content="Caterina Vivanet">
<meta name="citation_author_institution" content="SC Medical Genetics, ASSL Cagliari, 09126 Cagliari, Italy; francescaspina@hotmail.com (F.S.); luibale@hotmail.com (L.B.); cateviva@libero.it (C.V.)">
<meta name="citation_author" content="Alvaro Galli">
<meta name="citation_author_institution" content="Functional Genetics and Genomics Laboratory, Institute of Clinical Physiology, IFC-CNR, 56127 Pisa, Italy; f.belle01@hotmail.com (F.B.); tizicerv@ifc.cnr.it (T.C.)">
<meta name="citation_author" content="Maria Adelaide Caligo">
<meta name="citation_author_institution" content="SOD Molecular Genetics, University Hospital of Pisa, 56126 Pisa, Italy; chiara.guglielmi.cg@gmail.com (C.G.); eleonoraconti4@gmail.com (E.C.); mariella.tancredi@gmail.com (M.T.); cunegonda_f@yahoo.it (E.F.); c.cosini@ao-pisa.toscana.it (C.C.)">
<meta name="citation_publication_date" content="2021 Jul 19">
<meta name="citation_volume" content="22">
<meta name="citation_issue" content="14">
<meta name="citation_firstpage" content="7693">
<meta name="citation_doi" content="10.3390/ijms22147693">
<meta name="citation_pmid" content="34299313">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8305371/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8305371/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8305371/pdf/ijms-22-07693.pdf">
<meta name="description" content="With the progress of sequencing technologies, an ever-increasing number of variants of unknown functional and clinical significance (VUS) have been identified in both coding and non-coding regions of the main Breast Cancer (BC) predisposition genes. ...">
<meta name="og:title" content="Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory Regions">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="With the progress of sequencing technologies, an ever-increasing number of variants of unknown functional and clinical significance (VUS) have been identified in both coding and non-coding regions of the main Breast Cancer (BC) predisposition genes. ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8305371/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="8305371">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3390/ijms22147693"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/ijms-22-07693.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8305371%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/8305371/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/8305371/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8305371/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-ijms.png" alt="International Journal of Molecular Sciences logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to International Journal of Molecular Sciences" title="Link to International Journal of Molecular Sciences" shape="default" href="http://www.mdpi.com/journal/ijms/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Int J Mol Sci</button></div>. 2021 Jul 19;22(14):7693. doi: <a href="https://doi.org/10.3390/ijms22147693" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3390/ijms22147693</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Int%20J%20Mol%20Sci%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Int%20J%20Mol%20Sci%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Int%20J%20Mol%20Sci%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Int%20J%20Mol%20Sci%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory Regions</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guglielmi%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Chiara Guglielmi</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Chiara Guglielmi</span></h3>
<div class="p">
<sup>1</sup>SOD Molecular Genetics, University Hospital of Pisa, 56126 Pisa, Italy; chiara.guglielmi.cg@gmail.com (C.G.); eleonoraconti4@gmail.com (E.C.); mariella.tancredi@gmail.com (M.T.); cunegonda_f@yahoo.it (E.F.); c.cosini@ao-pisa.toscana.it (C.C.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guglielmi%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chiara Guglielmi</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Scarpitta%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Rosa Scarpitta</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Rosa Scarpitta</span></h3>
<div class="p">
<sup>2</sup>Division of Pathology, University of Pisa, 56126 Pisa, Italy; rose2312@hotmail.it</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Scarpitta%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rosa Scarpitta</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gambino%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Gaetana Gambino</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Gaetana Gambino</span></h3>
<div class="p">
<sup>3</sup>Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy; gaetana.gambino@gmail.com</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gambino%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Gaetana Gambino</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Conti%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Eleonora Conti</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Eleonora Conti</span></h3>
<div class="p">
<sup>1</sup>SOD Molecular Genetics, University Hospital of Pisa, 56126 Pisa, Italy; chiara.guglielmi.cg@gmail.com (C.G.); eleonoraconti4@gmail.com (E.C.); mariella.tancredi@gmail.com (M.T.); cunegonda_f@yahoo.it (E.F.); c.cosini@ao-pisa.toscana.it (C.C.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Conti%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Eleonora Conti</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bell%C3%A8%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Francesca Bellè</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Francesca Bellè</span></h3>
<div class="p">
<sup>4</sup>Functional Genetics and Genomics Laboratory, Institute of Clinical Physiology, IFC-CNR, 56127 Pisa, Italy; f.belle01@hotmail.com (F.B.); tizicerv@ifc.cnr.it (T.C.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bell%C3%A8%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Francesca Bellè</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tancredi%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Mariella Tancredi</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Mariella Tancredi</span></h3>
<div class="p">
<sup>1</sup>SOD Molecular Genetics, University Hospital of Pisa, 56126 Pisa, Italy; chiara.guglielmi.cg@gmail.com (C.G.); eleonoraconti4@gmail.com (E.C.); mariella.tancredi@gmail.com (M.T.); cunegonda_f@yahoo.it (E.F.); c.cosini@ao-pisa.toscana.it (C.C.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tancredi%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mariella Tancredi</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cervelli%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Tiziana Cervelli</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Tiziana Cervelli</span></h3>
<div class="p">
<sup>4</sup>Functional Genetics and Genomics Laboratory, Institute of Clinical Physiology, IFC-CNR, 56127 Pisa, Italy; f.belle01@hotmail.com (F.B.); tizicerv@ifc.cnr.it (T.C.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cervelli%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tiziana Cervelli</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Falaschi%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Elisabetta Falaschi</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Elisabetta Falaschi</span></h3>
<div class="p">
<sup>1</sup>SOD Molecular Genetics, University Hospital of Pisa, 56126 Pisa, Italy; chiara.guglielmi.cg@gmail.com (C.G.); eleonoraconti4@gmail.com (E.C.); mariella.tancredi@gmail.com (M.T.); cunegonda_f@yahoo.it (E.F.); c.cosini@ao-pisa.toscana.it (C.C.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Falaschi%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elisabetta Falaschi</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cosini%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Cinzia Cosini</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Cinzia Cosini</span></h3>
<div class="p">
<sup>1</sup>SOD Molecular Genetics, University Hospital of Pisa, 56126 Pisa, Italy; chiara.guglielmi.cg@gmail.com (C.G.); eleonoraconti4@gmail.com (E.C.); mariella.tancredi@gmail.com (M.T.); cunegonda_f@yahoo.it (E.F.); c.cosini@ao-pisa.toscana.it (C.C.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cosini%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Cinzia Cosini</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Aretini%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Paolo Aretini</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Paolo Aretini</span></h3>
<div class="p">
<sup>5</sup>Section of Oncological Genomics, Fondazione Pisana per la Scienza, 56017 Pisa, Italy; p.aretini@fpscience.it</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Aretini%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Paolo Aretini</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Congregati%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Caterina Congregati</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Caterina Congregati</span></h3>
<div class="p">
<sup>6</sup>Division of Internal Medicine, University Hospital of Pisa, 56126 Pisa, Italy; c.congregati@ao-pisa.toscana.it</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Congregati%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Caterina Congregati</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Marino%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Marco Marino</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Marco Marino</span></h3>
<div class="p">
<sup>7</sup>Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy; marcomarino83@gmail.com (M.M.); elena.tenedini@unimore.it (E.T.); enrico.tagliafico@unimore.it (E.T.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Marino%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marco Marino</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Patruno%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Margherita Patruno</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Margherita Patruno</span></h3>
<div class="p">
<sup>8</sup>IRCCS Istituto Tumori “Giovanni Paolo II”, 70124 Bari, Italy; m.patruno@oncologico.bari.it (M.P.); brunellapilato@gmail.com (B.P.); s.tommasi@oncologico.bari.it (S.T.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Patruno%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Margherita Patruno</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pilato%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Brunella Pilato</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Brunella Pilato</span></h3>
<div class="p">
<sup>8</sup>IRCCS Istituto Tumori “Giovanni Paolo II”, 70124 Bari, Italy; m.patruno@oncologico.bari.it (M.P.); brunellapilato@gmail.com (B.P.); s.tommasi@oncologico.bari.it (S.T.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pilato%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Brunella Pilato</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Spina%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Francesca Spina</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Francesca Spina</span></h3>
<div class="p">
<sup>9</sup>SC Medical Genetics, ASSL Cagliari, 09126 Cagliari, Italy; francescaspina@hotmail.com (F.S.); luibale@hotmail.com (L.B.); cateviva@libero.it (C.V.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Spina%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Francesca Spina</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Balestrino%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Luisa Balestrino</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Luisa Balestrino</span></h3>
<div class="p">
<sup>9</sup>SC Medical Genetics, ASSL Cagliari, 09126 Cagliari, Italy; francescaspina@hotmail.com (F.S.); luibale@hotmail.com (L.B.); cateviva@libero.it (C.V.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Balestrino%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Luisa Balestrino</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tenedini%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Elena Tenedini</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Elena Tenedini</span></h3>
<div class="p">
<sup>7</sup>Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy; marcomarino83@gmail.com (M.M.); elena.tenedini@unimore.it (E.T.); enrico.tagliafico@unimore.it (E.T.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tenedini%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elena Tenedini</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Carnevali%20I%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Ileana Carnevali</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Ileana Carnevali</span></h3>
<div class="p">
<sup>10</sup>Ospedale di Circolo ASST Settelaghi, 21100 Varese, Italy; ileana.carnevali@asst-settelaghi.it (I.C.); mariagrazia.tibiletti@asst-settelaghi.it (M.G.T.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Carnevali%20I%22%5BAuthor%5D" class="usa-link"><span class="name western">Ileana Carnevali</span></a>
</div>
</div>
<sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cortesi%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Laura Cortesi</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Laura Cortesi</span></h3>
<div class="p">
<sup>11</sup>Department of Oncology, Haematology and Respiratory Diseases, University Hospital of Modena, 41124 Modena, Italy; cortesilaura67@gmail.com</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cortesi%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Laura Cortesi</span></a>
</div>
</div>
<sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tagliafico%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Enrico Tagliafico</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">Enrico Tagliafico</span></h3>
<div class="p">
<sup>7</sup>Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy; marcomarino83@gmail.com (M.M.); elena.tenedini@unimore.it (E.T.); enrico.tagliafico@unimore.it (E.T.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tagliafico%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Enrico Tagliafico</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tibiletti%20MG%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Maria Grazia Tibiletti</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">Maria Grazia Tibiletti</span></h3>
<div class="p">
<sup>10</sup>Ospedale di Circolo ASST Settelaghi, 21100 Varese, Italy; ileana.carnevali@asst-settelaghi.it (I.C.); mariagrazia.tibiletti@asst-settelaghi.it (M.G.T.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tibiletti%20MG%22%5BAuthor%5D" class="usa-link"><span class="name western">Maria Grazia Tibiletti</span></a>
</div>
</div>
<sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tommasi%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id22"><span class="name western">Stefania Tommasi</span></a><div hidden="hidden" id="id22">
<h3><span class="name western">Stefania Tommasi</span></h3>
<div class="p">
<sup>8</sup>IRCCS Istituto Tumori “Giovanni Paolo II”, 70124 Bari, Italy; m.patruno@oncologico.bari.it (M.P.); brunellapilato@gmail.com (B.P.); s.tommasi@oncologico.bari.it (S.T.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tommasi%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Stefania Tommasi</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ghilli%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id23"><span class="name western">Matteo Ghilli</span></a><div hidden="hidden" id="id23">
<h3><span class="name western">Matteo Ghilli</span></h3>
<div class="p">
<sup>12</sup>Breast Cancer Center, University Hospital, 56126 Pisa, Italy; m.ghilli@ao-pisa.toscana.it</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ghilli%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Matteo Ghilli</span></a>
</div>
</div>
<sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vivanet%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id24"><span class="name western">Caterina Vivanet</span></a><div hidden="hidden" id="id24">
<h3><span class="name western">Caterina Vivanet</span></h3>
<div class="p">
<sup>9</sup>SC Medical Genetics, ASSL Cagliari, 09126 Cagliari, Italy; francescaspina@hotmail.com (F.S.); luibale@hotmail.com (L.B.); cateviva@libero.it (C.V.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vivanet%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Caterina Vivanet</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Galli%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id25"><span class="name western">Alvaro Galli</span></a><div hidden="hidden" id="id25">
<h3><span class="name western">Alvaro Galli</span></h3>
<div class="p">
<sup>4</sup>Functional Genetics and Genomics Laboratory, Institute of Clinical Physiology, IFC-CNR, 56127 Pisa, Italy; f.belle01@hotmail.com (F.B.); tizicerv@ifc.cnr.it (T.C.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Galli%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alvaro Galli</span></a>
</div>
</div>
<sup>4,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caligo%20MA%22%5BAuthor%5D" class="usa-link" aria-describedby="id26"><span class="name western">Maria Adelaide Caligo</span></a><div hidden="hidden" id="id26">
<h3><span class="name western">Maria Adelaide Caligo</span></h3>
<div class="p">
<sup>1</sup>SOD Molecular Genetics, University Hospital of Pisa, 56126 Pisa, Italy; chiara.guglielmi.cg@gmail.com (C.G.); eleonoraconti4@gmail.com (E.C.); mariella.tancredi@gmail.com (M.T.); cunegonda_f@yahoo.it (E.F.); c.cosini@ao-pisa.toscana.it (C.C.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caligo%20MA%22%5BAuthor%5D" class="usa-link"><span class="name western">Maria Adelaide Caligo</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>
</div>
<div class="cg p">Editor: <span class="name western">Paola Ghiorzo</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="af1-ijms-22-07693">
<sup>1</sup>SOD Molecular Genetics, University Hospital of Pisa, 56126 Pisa, Italy; chiara.guglielmi.cg@gmail.com (C.G.); eleonoraconti4@gmail.com (E.C.); mariella.tancredi@gmail.com (M.T.); cunegonda_f@yahoo.it (E.F.); c.cosini@ao-pisa.toscana.it (C.C.)</div>
<div id="af2-ijms-22-07693">
<sup>2</sup>Division of Pathology, University of Pisa, 56126 Pisa, Italy; rose2312@hotmail.it</div>
<div id="af3-ijms-22-07693">
<sup>3</sup>Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy; gaetana.gambino@gmail.com</div>
<div id="af4-ijms-22-07693">
<sup>4</sup>Functional Genetics and Genomics Laboratory, Institute of Clinical Physiology, IFC-CNR, 56127 Pisa, Italy; f.belle01@hotmail.com (F.B.); tizicerv@ifc.cnr.it (T.C.)</div>
<div id="af5-ijms-22-07693">
<sup>5</sup>Section of Oncological Genomics, Fondazione Pisana per la Scienza, 56017 Pisa, Italy; p.aretini@fpscience.it</div>
<div id="af6-ijms-22-07693">
<sup>6</sup>Division of Internal Medicine, University Hospital of Pisa, 56126 Pisa, Italy; c.congregati@ao-pisa.toscana.it</div>
<div id="af7-ijms-22-07693">
<sup>7</sup>Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy; marcomarino83@gmail.com (M.M.); elena.tenedini@unimore.it (E.T.); enrico.tagliafico@unimore.it (E.T.)</div>
<div id="af8-ijms-22-07693">
<sup>8</sup>IRCCS Istituto Tumori “Giovanni Paolo II”, 70124 Bari, Italy; m.patruno@oncologico.bari.it (M.P.); brunellapilato@gmail.com (B.P.); s.tommasi@oncologico.bari.it (S.T.)</div>
<div id="af9-ijms-22-07693">
<sup>9</sup>SC Medical Genetics, ASSL Cagliari, 09126 Cagliari, Italy; francescaspina@hotmail.com (F.S.); luibale@hotmail.com (L.B.); cateviva@libero.it (C.V.)</div>
<div id="af10-ijms-22-07693">
<sup>10</sup>Ospedale di Circolo ASST Settelaghi, 21100 Varese, Italy; ileana.carnevali@asst-settelaghi.it (I.C.); mariagrazia.tibiletti@asst-settelaghi.it (M.G.T.)</div>
<div id="af11-ijms-22-07693">
<sup>11</sup>Department of Oncology, Haematology and Respiratory Diseases, University Hospital of Modena, 41124 Modena, Italy; cortesilaura67@gmail.com</div>
<div id="af12-ijms-22-07693">
<sup>12</sup>Breast Cancer Center, University Hospital, 56126 Pisa, Italy; m.ghilli@ao-pisa.toscana.it</div>
<div class="author-notes p"><div class="fn" id="c1-ijms-22-07693">
<sup>*</sup><p class="display-inline">Correspondence: <span>alvaro.galli@ifc.cnr.it</span> (A.G.); <span>adelaide.caligo@do.unipi.it</span> (M.A.C.)</p>
</div></div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Paola Ghiorzo</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2021 Jun 12; Accepted 2021 Jul 14; Collection date 2021 Jul.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2021 by the authors.</div>
<p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://creativecommons.org/licenses/by/4.0/</a>).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC8305371  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34299313/" class="usa-link">34299313</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>With the progress of sequencing technologies, an ever-increasing number of variants of unknown functional and clinical significance (VUS) have been identified in both coding and non-coding regions of the main Breast Cancer (BC) predisposition genes. The aim of this study is to identify a mutational profile of coding and intron-exon junction regions of 12 moderate penetrance genes (<em>ATM</em>, <em>BRIP1</em>, <em>CDH1</em>, <em>CHEK2</em>, <em>NBN</em>, <em>PALB2</em>, <em>PTEN</em>, <em>RAD50</em>, <em>RAD51C</em>, <em>RAD51D</em>, <em>STK11</em>, <em>TP53</em>) in a cohort of 450 Italian patients with Hereditary Breast/Ovarian Cancer Syndrome, <em>wild type</em> for germline mutation in <em>BRCA1/2</em> genes. The analysis was extended to 5′UTR and 3′UTR of all the genes listed above and to the BRCA1 and BRCA2 known regulatory regions in a subset of 120 patients. The screening was performed through NGS target resequencing on the Illumina platform MiSeq. 8.7% of the patients analyzed is carriers of class 5/4 coding variants in the <em>ATM</em> (3.6%), <em>BRIP1</em> (1.6%), <em>CHEK2</em> (1.8%), <em>PALB2</em> (0.7%), <em>RAD51C</em> (0.4%), <em>RAD51D</em> (0.4%), and <em>TP53</em> (0.2%) genes, while variants of uncertain pathological significance (VUSs)/class 3 were identified in 9.1% of the samples. In intron-exon junctions and in regulatory regions, variants were detected respectively in 5.1% and in 32.5% of the cases analyzed. The average age of disease onset of 44.4 in non-coding variant carriers is absolutely similar to the average age of disease onset in coding variant carriers for each proband’s group with the same cancer type. Furthermore, there is not a statistically significant difference in the proportion of cases with a tumor onset under age of 40 between the two groups, but the presence of multiple non-coding variants in the same patient may affect the aggressiveness of the tumor and it is worth underlining that 25% of patients with an aggressive tumor are carriers of a <em>PTEN</em> 3′UTR-variant. This data provides initial information on how important it might be to extend mutational screening to the regulatory regions in clinical practice.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> hereditary breast and ovarian cancer, BRCA1/2, breast cancer predisposition genes, coding variants, non-coding variants, regulatory regions, gene panel, NGS</p></section></section><section id="sec1-ijms-22-07693"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Breast cancer (BC) is the most common malignant tumor in women representing 25% of the total number of cancer cases in women with an annual increase of 793,700 new cases and 197,600 deaths only in developed countries [<a href="#B1-ijms-22-07693" class="usa-link" aria-describedby="B1-ijms-22-07693">1</a>,<a href="#B2-ijms-22-07693" class="usa-link" aria-describedby="B2-ijms-22-07693">2</a>].</p>
<p>The presence of germline mutations in the <em>BRCA1</em> and <em>BRCA2</em> genes significantly increases the risk of developing breast and ovarian cancer [<a href="#B3-ijms-22-07693" class="usa-link" aria-describedby="B3-ijms-22-07693">3</a>,<a href="#B4-ijms-22-07693" class="usa-link" aria-describedby="B4-ijms-22-07693">4</a>,<a href="#B5-ijms-22-07693" class="usa-link" aria-describedby="B5-ijms-22-07693">5</a>], however only 25% of the risk of familial cancer can be attributed to pathogenetic mutations localized in the coding regions of these two genes. Most of the risk is probably due to a combination of high, moderate, and low risk variants which may also include non-coding variants located in regulatory regions [<a href="#B4-ijms-22-07693" class="usa-link" aria-describedby="B4-ijms-22-07693">4</a>].</p>
<p>In clinical practice, during the past years, the mutational analysis in patients with Hereditary Breast and Ovarian Cancer (HBOC) has been mostly limited to the coding regions and to the intron-exon junctions of <em>BRCA1</em> and <em>BRCA2</em>, precluding the identification of mutations in the non-coding and/or regulatory regions and in other genes that can confer a high or moderate risk to the disease. Under these conditions, mutation screening is negative in 80% of the cases analyzed [<a href="#B6-ijms-22-07693" class="usa-link" aria-describedby="B6-ijms-22-07693">6</a>].</p>
<p>Segregation analysis generated no evidence for further dominant genes with a risk penetrance profile comparable to <em>BRCA1</em> or <em>BRCA2</em> and this has been corroborated by linkage studies [<a href="#B7-ijms-22-07693" class="usa-link" aria-describedby="B7-ijms-22-07693">7</a>,<a href="#B8-ijms-22-07693" class="usa-link" aria-describedby="B8-ijms-22-07693">8</a>]. Over the years, efforts have been made to identify new intermediate-penetrance predisposition genes, although it is difficult to predict how many they might be and what proportion of the total familial risk is attributable to them. The known intermediate-penetrance genes are all involved in DNA repair or have a role in BRCA1 or BRCA2 pathway, so these genes represent plausible candidates and are the most intensively investigated [<a href="#B9-ijms-22-07693" class="usa-link" aria-describedby="B9-ijms-22-07693">9</a>]. In addition, in recent years, the interest in investigating the effect that regulatory variants could have on cancer risk has increased [<a href="#B10-ijms-22-07693" class="usa-link" aria-describedby="B10-ijms-22-07693">10</a>].</p>
<p>Generally, gene expression is controlled at various levels by key regulatory elements located in promoters, introns, in “long-range enhancers” and in Untranslated Regions (5′and 3′ UTR). This is also true for <em>BRCA1</em> and <em>BRCA2</em>; in fact, it has been shown that the activity of the 5′UTR and of the <em>BRCA1/2</em> exon-flanking regions is controlled by a self-regulation mechanism and by an increasing number of transcription factors that act as activators or repressors. Interestingly, germline variants of 5′UTR causing a significant change in promoter activity have been identified in such regions [<a href="#B11-ijms-22-07693" class="usa-link" aria-describedby="B11-ijms-22-07693">11</a>,<a href="#B12-ijms-22-07693" class="usa-link" aria-describedby="B12-ijms-22-07693">12</a>,<a href="#B13-ijms-22-07693" class="usa-link" aria-describedby="B13-ijms-22-07693">13</a>].</p>
<p>Similarly, germline variants localized in consensus regions for “RNA binding protein” and miRNA located in 3′UTR of <em>BRCA1</em> [<a href="#B14-ijms-22-07693" class="usa-link" aria-describedby="B14-ijms-22-07693">14</a>,<a href="#B15-ijms-22-07693" class="usa-link" aria-describedby="B15-ijms-22-07693">15</a>] and <em>PTEN</em> [<a href="#B16-ijms-22-07693" class="usa-link" aria-describedby="B16-ijms-22-07693">16</a>,<a href="#B17-ijms-22-07693" class="usa-link" aria-describedby="B17-ijms-22-07693">17</a>] have been associated with breast cancer risk.</p>
<p>Therefore, germline regulatory variants can be associated with a deregulation of the transcriptional activity and modify the physiological expression both of BRCA genes and of other genes that can affect the risk of breast cancer [<a href="#B13-ijms-22-07693" class="usa-link" aria-describedby="B13-ijms-22-07693">13</a>].</p>
<p>With the progression of DNA sequencing technologies, it is possible to analyze in each patient multiple genomic regions by simultaneously screening multiple target genes.</p>
<p>An ever-increasing number of variants of unknown functional and clinical significance (VUS) have been identified in both coding and non-coding regions. Therefore, it is absolutely necessary to establish their risk level in carrier patients, for more effective genetic counselling.</p>
<p>In 2008, the International Agency for Research on Cancer (IARC) proposed to classify the missense variants on the basis of their probable pathogenicity, calculated by multifactorial models, in five risk classes: Class 1 (non-pathogenic or of no clinical significance), Class 2 (likely non-pathogenic or of little clinical significance), Class 3 (uncertain), Class 4 (likely pathogenic), and Class 5 (definitely pathogenic) [<a href="#B18-ijms-22-07693" class="usa-link" aria-describedby="B18-ijms-22-07693">18</a>].</p>
<p>Recently, the indications of the American College of Medical Genetics (ACMG) have been increasingly followed by several clinicians and research groups. They have recommended a five-tier classification system where variants can be classified as: ‘Pathogenic’, ‘Likely pathogenic’, ‘Uncertain significance’, ‘Likely benign’, and ‘Benign’ [<a href="#B19-ijms-22-07693" class="usa-link" aria-describedby="B19-ijms-22-07693">19</a>]. </p>
<p>In this work we used this classification that, among those available, is the most complete and is based on an algorithm that takes into account data on penetrance, clinical information of carriers, and scientific evidence.</p>
<p>To classify VUSs, alternative methods have also been developed. They do not directly evaluate the role of the variant in the development of cancer, but the structural and functional modifications of the proteins of interest by providing indirect evidence of the pathogenicity of the variant [<a href="#B20-ijms-22-07693" class="usa-link" aria-describedby="B20-ijms-22-07693">20</a>,<a href="#B21-ijms-22-07693" class="usa-link" aria-describedby="B21-ijms-22-07693">21</a>]. Both in vitro functional assays and in silico predictors can be used [<a href="#B20-ijms-22-07693" class="usa-link" aria-describedby="B20-ijms-22-07693">20</a>].</p>
<p>Recently the international consortium ENIGMA (Evidence-based Network for the Interpretation of Germline Mutant Alleles) has become in charge of reviewing and comparing all the available and useful functional tests in order to define the functional meaning of a variant and to contribute to the interpretation of clinical data [<a href="#B22-ijms-22-07693" class="usa-link" aria-describedby="B22-ijms-22-07693">22</a>,<a href="#B23-ijms-22-07693" class="usa-link" aria-describedby="B23-ijms-22-07693">23</a>,<a href="#B24-ijms-22-07693" class="usa-link" aria-describedby="B24-ijms-22-07693">24</a>,<a href="#B25-ijms-22-07693" class="usa-link" aria-describedby="B25-ijms-22-07693">25</a>].</p>
<p>In this study involving five Italian hospital centers (Pisa, Cagliari, Varese, Modena, and Bari), a genomic screening was conducted on 450 Breast and/or Ovarian Cancer patients with cancer family history in at least two generations and wild type for germinal mutations in the coding regions and/or for large rearrangements in BRCA1/2 genes.</p>
<p>The analysis was carried out by Next Generation Sequencing (NGS) using a panel that covers the coding regions and the intron-exon junctions of 10 genes mainly involved in DNA repair pathways: <em>ATM</em>, <em>BRIP1</em>, <em>CDH1</em>, <em>CHECK2</em>, <em>PALB2</em>, <em>PTEN</em>, <em>RAD51C</em>, <em>RAD51D</em>, <em>STK11</em>, <em>TP53</em>. For 120 of these patients, the screening was extended to RAD50 and NBN genes and to 5′UTR and 3′UTR of all the genes listed above including the known regulatory regions of <em>BRCA1</em> and <em>BRCA2</em>. We hypothesized that variants located in the regulatory regions of the main BC predisposition genes can contribute to tumor development in a manner comparable to the variants located in coding regions. To support this hypothesis, we compared the average age of disease onset between the coding and the non-coding variant carriers with the same cancer type. Moreover, we analyzed the proportion of cases with a tumor onset under the age of 40 between the two groups and we verified any variant association in more aggressive tumours.</p></section><section id="sec2-ijms-22-07693"><h2 class="pmc_sec_title">2. Results</h2>
<section id="sec2dot1-ijms-22-07693"><h3 class="pmc_sec_title">2.1. Summary Overview of Germline Variants Found</h3>
<p>Mutational screening was performed for 450 patients in the coding regions and 50 bp flanking intronic sequences of 10 genes: <em>ATM</em>, <em>BRIP1</em>, <em>CDH1</em>, <em>CHECK2</em>, <em>PALB2</em>, <em>PTEN</em>, <em>RAD51C</em>, <em>RAD51D</em>, <em>STK11</em>, <em>TP53</em>. For 120 of these patients, the analysis was extended to two additional genes, <em>RAD50</em> and <em>NBN</em>, and to the regulatory regions of <em>BRCA1</em> and <em>BRCA2</em>, 5′UTR, and 3′UTR for all 12 genes listed above. </p>
<p>We identified 88 coding variants in 91 patients distributed as follows:</p>
<ul class="list" style="list-style-type:none">
<li>
<span class="label">-</span><p class="display-inline">16 class 4 (Likely-pathogenic) and 19 class 5 (Pathogenic) variants in 39 patients (8.7%)</p>
</li>
<li>
<span class="label">-</span><p class="display-inline">37 class 3 (VUS) in 41 patients (9.1%)</p>
</li>
<li>
<span class="label">-</span><p class="display-inline">16 Likely-benign variants in 19 patients (4.2%), but all of them potentially classifiable as VUS, according to ACMG classification, because of interpretation conflicts.</p>
</li>
</ul>
<p>In the intron-exon junctions, 13 variants in 23 patients were identified (5.1%).</p>
<p>The extension of the screening in 120 patients to the known regulatory regions of <em>BRCA1/2</em> and to 5′UTR, 3′UTR for all the genes analyzed, allowed us to identify another 51 variants in 39 patients (32.5%).</p></section><section id="sec2dot2-ijms-22-07693"><h3 class="pmc_sec_title">2.2. Coding Variants</h3>
<p>A total of 88 coding variants were identified: 35 Pathogenic or Likely-pathogenic variants, 37 VUS, and 16 Likely-benign variants.</p>
<p>Thirty out of 35 Pathogenic or Likely-pathogenic identified coding variants were encoded in dbSNP and 27 were already known in literature or reported in databases such as IARC, LOVD, MGeND, ClinVar Miner with more clinical information. Five variants have never been registered: c.8368delA in <em>ATM</em>, c.507delT and c.1430delC in <em>CHEK2</em>, c.1565dupC in <em>PALB2</em>, c.397_398delCA in <em>RAD51C</em>. The 35 class 4 and 5 variants are distributed in the following genes: 14 in <em>ATM</em>, 5 in <em>BRIP1</em>, 8 in <em>CHEK2</em>, 3 in <em>PALB2</em>, 2 in <em>RAD51C</em>, 2 in <em>RAD51D</em>, and 1 in <em>TP53</em>.</p>
<p>Thirty-four out of 37 VUS identified were encoded in dbSNP and 25 of these were already known and reported in databases previously cited. The following 3 VUSs were completely new: c.2317A &gt; G in ATM, c.3029A &gt; G in BRIP1 and c.17_18insGCG in <em>PTEN</em>. Eighteen of the 37 VUSs identified are in <em>ATM</em>, 5 in <em>BRIP1</em>, 2 in <em>CDH1</em>, 1 in <em>CHEK2</em>, 3 in <em>NBN</em>, 3 in PALB2, 2 in <em>PTEN</em>, 2 <em>in RAD50</em>, and 1 in <em>STK11</em>.</p>
<p>Fifteen out of 16 Likely-benign variants found had a dbSNP entrie and 12 of these were encoded in databases. One variant had never been registered (c.252T &gt; C in <em>RAD51D</em>). The 16 Likely-benign variants are distributed as follows: 4 in <em>ATM</em>, 1 in <em>BRIP1</em>, 3 in <em>CDH1</em>, 1 in <em>CHEK2</em>, 2 in <em>RAD50</em>, 1 in <em>RAD51C</em>, 3 in <em>RAD51D</em>, and 1 in <em>STK11</em>.</p>
<p><a href="#ijms-22-07693-f001" class="usa-link">Figure 1</a> shows the percentage of distributions of the variants stratified by gene, according to the current ACMG classification. As shown in <a href="#ijms-22-07693-f001" class="usa-link">Figure 1</a>
<em>ATM</em> is the gene with the highest mutation rate. </p>
<figure class="fig xbox font-sm" id="ijms-22-07693-f001"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8305371_ijms-22-07693-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f77/8305371/ecfcd8a5b9cc/ijms-22-07693-g001.jpg" loading="lazy" height="430" width="744" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/ijms-22-07693-f001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Percentage of identified coding variants distributed by gene and by clinical classification. P/LP = pathogenic/likely pathogenic, VUS = variant of uncertain significance, LB = likely benign.</p></figcaption></figure><p>Sixty-six out of 88 identified variants are missense variants (of which 18 Pathogenic and Likely-pathogenic, 35 VUS and 13 Likely-benign), 5 Nonsense variants (all Pathogenic), 4 Synonymous variants (1 VUS and 3 Likely-benign), 11 frameshift variants (all Pathogenic), and 2 in-frame variants (1VUS and 1 Pathogenic). The distribution by gene is shown in <a href="#ijms-22-07693-f002" class="usa-link">Figure 2</a>.</p>
<figure class="fig xbox font-sm" id="ijms-22-07693-f002"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8305371_ijms-22-07693-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f77/8305371/6268f0c3f1a1/ijms-22-07693-g002.jpg" loading="lazy" height="479" width="795" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/ijms-22-07693-f002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Distribution of 88 variants by effect and by clinical classification (P = Pathogenic/Likely-pathogenic, V = VUS, B = Likely-benign).</p></figcaption></figure><p>The predictive analysis on the effect of amino acid change on the function of the protein was conducted with PROVEAN and Polyphen2 software, as described in Materials and Methods. Specifically, the information for each identified variant is shown in <a href="#app1-ijms-22-07693" class="usa-link">Table S1 in Supplementary Materials</a>, where it is also reported whether the variant has already been identified and registered in database by other groups.</p></section><section id="sec2dot3-ijms-22-07693"><h3 class="pmc_sec_title">2.3. Demographics and Clinical Features of Patiens with Coding Variants</h3>
<p>The average age of tumor diagnosis for 91 patients with coding variants is 44. 8.8% (8) of the patients have a bilateral BC, 2.2% (2) have both breast and ovarian cancer, 4.4% (4) have ovarian cancer, 2.2% (2) have multiple tumors (in addition to breast cancers) and the remaining percentage, 82.4% (75) of total cases, has a BC. Among the latter patients, 16% (12) have Triple-Negative Breast Cancer (TNBC).</p>
<p>Their family histories are distributed as follows: 48.3% (44) have Hereditary Breast Cancer (HBC), 12.1% (11) have Hereditary Breast and Ovarian Cancer (HBOC), 18.7% (17) have Early Onset Breast Cancer (EOBC), and 20.9% (19) have other Hereditary Breast Cancer Syndromes (HBCS) (<a href="#ijms-22-07693-t001" class="usa-link">Table 1</a>).</p>
<section class="tw xbox font-sm" id="ijms-22-07693-t001"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Coding variant carrier characteristics: percentage distribution of probands according to the cancer they are affected by and to their cancer family history. The number of patients is shown in brackets. The average age at disease onset is reported for each proband kind of cancer (for patients with bilateral breast cancer and multiple tumors, the age of onset of initial tumor has been considered).</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Coding Variant Carrier Characteristics</th></tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patient number</td>
<td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">91</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Average age of cancer onset</td>
<td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">44</td>
</tr>
<tr>
<td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<strong>Proband cancer kind</strong>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Average age at onset</strong>
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast cancer</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82.4% (75)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42.8</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bilateral Breast Cancer</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.8% (8)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45.7</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ovarian cancer</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.4% (4)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.7</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast and ovarian cancer</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.2% (2)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.5</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast/Ovarian Cancer and other tumors</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2.2% (2)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">54.5</td>
</tr>
<tr><td colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">
<strong>Proband cancer history</strong>
</td></tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HBC</td>
<td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">48.3% (44)</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HBOC</td>
<td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">12.1% (11)</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EOBC</td>
<td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">18.7% (17)</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Other HBCS</td>
<td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">20.9% (19)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/ijms-22-07693-t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Thirty-nine patients are carriers of variants classified as “Pathogenic” or “Likely-pathogenic”, 41 patients are carriers of VUS, while “Likely-benign” variants have been identified in 19 patients. If we consider the total number of patients screened in the coding regions (450) the percentage of class 4 and 5 variant carriers is 8.7% and it is distributed in this way: 3.6% have variants in <em>ATM</em>, 1.6% in <em>BRIP1</em>, 1.8% in <em>CHEK2</em>, 0.7% in <em>PALB2</em>, 0.4% in <em>RAD51C</em>, 0.4% in <em>RAD51D</em>, and 0.2% in <em>TP53</em>. In <a href="#ijms-22-07693-f003" class="usa-link">Figure 3</a> the frequencies of patients with Pathogenic and Likely-pathogenic, VUS and Likely-benign variants are reported.</p>
<figure class="fig xbox font-sm" id="ijms-22-07693-f003"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8305371_ijms-22-07693-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f77/8305371/bd10b1be6a94/ijms-22-07693-g003.jpg" loading="lazy" height="453" width="718" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/ijms-22-07693-f003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Percentages of coding-variant carriers distributed by gene and by clinical classification out of the total of 450 cases screened.</p></figcaption></figure><p>Among the 75 patients with BC, we identified 82 variants of which 30 Pathogenic and Likely-pathogenic, broken down as follows: 13 in <em>ATM</em> gene, 5 in <em>BRIP1</em>, 2 in <em>PALB2</em>, 6 in <em>CHEK2</em>, 2 in <em>RAD51C</em>, 1 in <em>RAD51D</em> and 1 in <em>TP53</em>. In these same patients we identified 38 VUS: 15 in <em>ATM</em>, 6 in <em>BRIP1</em>, 4 in <em>CDH1</em>, 3 in <em>NBN</em>, 3 in <em>PALB2</em>, 2 in <em>CHEK2</em>, 2 in <em>PTEN</em>, 1 in <em>RAD50</em>, 1 in <em>RAD51D</em> and 1 in <em>STK11</em>. The 14 remaining variants found are classified as Likely-benign and distributed as follows: 6 in <em>ATM</em>, 3 in <em>RAD51D</em>, 2 in <em>CDH1</em> and 3 respectively in <em>BRIP1</em>, <em>RAD50</em>, and <em>RAD51C</em> genes. </p>
<p>Among the four cases of patients with ovarian cancer, we found a Pathogenic variant in <em>RAD51C</em>, 2 VUSs, respectively in <em>ATM</em> and <em>RAD50</em> genes, and a Likely-benign variant in <em>STK11</em>.</p>
<p>Among the 12 cases of multiple tumors in coding variant carriers (9 cases of bilateral breast cancer, 2 of breast and ovarian cancer, and 1 case of breast tumor associated with pancreatic cancer), 9 have Pathogenic or Likely-pathogenic variants, 1 VUS and 2 Likely-benign variants. The statistical analysis has found a significant association of these cases with Pathogenic variant carriers (χ2-test, <em>p</em> &lt; 0.01) in comparison with the cases of single tumors.</p>
<p>Three out of nine patients with Pathogenic variants have variants in <em>ATM</em>, 4 in <em>CHEK2</em>, 1 in <em>BRIP1</em> and 1 in <em>PALB2</em> (<a href="#ijms-22-07693-t002" class="usa-link">Table 2</a>). Three of these nine variants are new variants never reported in dbSNP. One case has a VUS in <em>ATM</em> gene and two patients with multiple tumors have Likely-benign variants in CDH1 and <em>CHEK2</em> genes. Frequency of coding variants in <em>CHEK2</em> gene is significant in these patients (Fisher test, <em>p</em> &lt; 0.05).</p>
<section class="tw xbox font-sm" id="ijms-22-07693-t002"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>List of variants found among the 12 cases of patients with multiple tumors in coding-variant carriers. The table reports the protein change of variant, the clinical classification (P = Pathogenic, LP = Likely-pathogenic, VUS = Variant of Unknown Clinical Significance, and LB = Likely-benign), the variant frequency among these 12 cases, the patient cancer type in which they were detected and the eventual database registration. The variants are reported in HGVS nomenclature.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr><th colspan="8" align="center" valign="middle" style="border-top:solid thin" rowspan="1">Variants in 12 Cases of Multiple Tumors</th></tr>
<tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Variant</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Protein Change</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Classification</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">N.patients</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Tumor</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">dbSNP</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Database</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.3894dupT </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Ala1299CysfsTer3</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bil. Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs587781823</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ClinVar Miner</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.8368delA </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Arg2790AspfsTer16</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bil. Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.3284G &gt; A </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Arg1095Lys</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Br/Ov </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs587781815</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LOVD</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.2237_2240delTCAA </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Ile746AsnfsTer12</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BRIP1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bil.Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs587782726</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MGeND</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1312G &gt; T </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Val438Phe</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CHEK2</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bil.Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs58778017</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LOVD</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.483_485delAGA </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Glu204del</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CHEK2</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bil.Breast/Pancr.</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs587782008</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MGeND</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.507delT </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Asp169GlufsTer5</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CHEK2</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Br/Ov </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1430delC </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Thr477LysfsTer7</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CHEK2</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bil.Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1451T &gt; A </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Leu484Ter</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PALB2</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bil.Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs786203714</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ClinVar Miner</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1516G &gt; T </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Gly506Cys</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bil.Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs587779816</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LOVD</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.131G &gt; T </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Arg44Leu</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CDH1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LB</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bil.Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs1375178645</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.132C &gt; T </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Ser44=</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CHEK2</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LB</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bil.Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs199715101</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ClinVar Miner</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/ijms-22-07693-t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>By analyzing cases of more aggressive tumors such as the 12 Triple-negative breast cancer patients (TNBC) (<a href="#ijms-22-07693-t003" class="usa-link">Table 3</a>), all with G2 or G3 infiltrating ductal carcinoma, we identified 6 Pathogenic and Likely-pathogenic variants: 1 in <em>ATM</em>, 1 in <em>BRIP1</em>, 2 in <em>CHEK2</em>, 1 in <em>RAD51D</em> and 1 in <em>TP53</em>. In 6 patients, 4 VUSs (3 in ATM and 1 in <em>PTEN</em> never recorded before) and 2 Likely-benign variants were identified. The latter all have a conserved evolutionary profile (GERP &gt; 3.8) and a conflict of interpretation according to Varsome and ClinVar.</p>
<section class="tw xbox font-sm" id="ijms-22-07693-t003"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>List of variants identified in 12 cases of patients with Triple-Negative Breast cancer (TNBC). The table also reports the protein change for each variant, their clinical classification (P = Pathogenic, LP = Likely-pathogenic, VUS = Variant of Unknown clinical Significance, LB = Likely-benign), their frequency identified in these patients and whether they have been previously recorded in the database LOVD. The variants are reported in HGVS nomenclature.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr><th colspan="7" align="center" valign="middle" style="border-top:solid thin" rowspan="1">Variants in 12 Cases of TNBC</th></tr>
<tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Variant</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Protein Change</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Classification</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">N.patients</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">dbSNP</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Database</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.6067G &gt; A </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Gly2023Arg</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs11212587</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LOVD</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.2392C &gt; T </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Arg798Ter</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BRIP1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs137852986</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LOVD</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.409C &gt; T </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Arg137Ter</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CHEK2</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs730881701</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LOVD</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1118A &gt; G </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Gln373Arg</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CHEK2</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs894075046</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LOVD</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.694C &gt; T </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Arg232Ter</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RAD51D</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs587780104</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LOVD</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.817C &gt; G </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Arg273Gly</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TP53</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs121913343</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LOVD</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1272T &gt; C </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Pro424=</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs35578748</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LOVD</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.4703A &gt; G </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.His1568Arg</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs368830730</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LOVD</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.4060C &gt; A </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Pro1354Thr</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs145119475</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LOVD</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.17_18insGCG </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Lys6_Glu7insArg</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PTEN</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.2119T &gt; C</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Ser707Pro</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LB</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs4986761</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LOVD</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1810C &gt; T </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Pro604Ser</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LB</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs2227922</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LOVD</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/ijms-22-07693-t003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec2dot4-ijms-22-07693"><h3 class="pmc_sec_title">2.4. Non-Coding and/or Regulatory Variants</h3>
<p>The screening of non-coding regions has allowed us to identify 64 variants. Forty-six of these have a dbSNP code and only 24 are known variants already registered in databases by other groups.</p>
<p>The 64 variants are distributed as follows: 18 are located at 5′UTR, 21 at 3′UTR, 6 in splice site regions, and 19 in intron regions.</p>
<p><a href="#ijms-22-07693-f004" class="usa-link">Figure 4</a> shows the distribution of the variants by gene divided according to their location.</p>
<figure class="fig xbox font-sm" id="ijms-22-07693-f004"><h4 class="obj_head">Figure 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8305371_ijms-22-07693-g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f77/8305371/0c9b140bd210/ijms-22-07693-g004.jpg" loading="lazy" height="405" width="771" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/ijms-22-07693-f004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Non-coding variant distribution by gene and by gene region (5′UTR, 3′UTR, Splice regions, and Intron regions).</p></figcaption></figure><p><em>ATM</em>, <em>BRCA1</em>, <em>BRCA2</em>, and <em>PTEN</em> are among the genes in which we have found more non-coding variants (<a href="#ijms-22-07693-f004" class="usa-link">Figure 4</a>).</p>
<p>The variant putative effect on gene expression, was carried out by using different software (described in Materials and Methods) depending on variant position. The results are reported in <a href="#app1-ijms-22-07693" class="usa-link">Table S2a–d in Supplementary Materials</a>.</p>
<p>An unexpectedly high number of variants in 5′ UTR of <em>PTEN</em> (4) and <em>RAD51C</em> (3) was found and, according to our analysis, all of them are localized in TF binding regions (<a href="#app1-ijms-22-07693" class="usa-link">Table S2a/Supplementary Materials</a>).</p>
<p>The in-silico analysis performed by ‘TFbind’ and ‘Promo’ software, has identified TF consensus sequences in the regions where the 5′UTR of <em>BRCA1</em> (c.-676T &gt; A) and <em>BRCA2</em> (c.-1193C &gt; T) variants are localized (<a href="#app1-ijms-22-07693" class="usa-link">Table S2a/Supplementary Materials</a>).</p>
<p>In 3′UTR, the greatest contribution is due to variants located in <em>ATM</em>, <em>PTEN</em>, and <em>RAD50</em> genes (<a href="#ijms-22-07693-f004" class="usa-link">Figure 4</a>) on which putative miRNA-binding regions have been identified by ‘TargetScanHuman’ and ‘miRDB’ software (<a href="#app1-ijms-22-07693" class="usa-link">Table S2b/Supplementary Materials</a>).</p>
<p>In splicing regions, we identified six variants and only one, c.904+5G &gt; T, was predicted to inactivate the wild-type donor site in the intron 6 of the <em>RAD51C</em> gene, and therefore is classified by the ACMG criteria as ‘Pathogenic’.</p>
<p>Three variants were in <em>ATM</em> but only the c.7788+ 8G &gt; T, localized in intron 52, was predicted by ‘Human Splicing Finder’ as a possible modifier of an exonic ESE site with a potential alteration of splicing. The remaining 2 in <em>CHEK2</em> and <em>BRIP1</em> genes were predicted neutral on splicing (<a href="#app1-ijms-22-07693" class="usa-link">Table S2c/Supplementary materials</a>).</p>
<p>In the remaining intronic regions, variants in <em>ATM</em>, <em>BRCA1</em>, <em>BRCA2</em>, <em>CHEK2</em>, <em>NBN</em>, <em>RAD50</em>, <em>STK11</em>, and <em>TP53</em> genes were identified. The possible presence of enhancer regions, compatible with bonds to transcription factors, was analyzed by the software mentioned above. The four variants identified in intron 2 of <em>BRCA1</em> (c.81-3510_81-3505delCTTTTT; c.81-3790G &gt; C; c.81-4100A &gt; C; c.80 + 247C &gt; T) deserve attention. In fact, all four variants identified in this study map in two conserved enhancer regions, that have already been demonstrated to be involved in gene expression regulation (<a href="#app1-ijms-22-07693" class="usa-link">Table S2d/Supplementary Materials</a>) [<a href="#B26-ijms-22-07693" class="usa-link" aria-describedby="B26-ijms-22-07693">26</a>]. </p>
<p>In conclusion, we found only one Pathogenic variant in the <em>RAD51C</em> gene, whereas the large majority were classified as VUSs (50), 2 as Likely-benign and 11 as Benign variants. </p>
<p>The high number of VUSs is due to the fact that very few studies have analyzed these non-coding regions, and for this reason the classification is based only on in silico prediction.</p></section><section id="sec2dot5-ijms-22-07693"><h3 class="pmc_sec_title">2.5. Deep Intronic Regions</h3>
<p>The panel of 9071 probes used was designed to optimize coverage of exonic regions, 50 bp flanking each intron-exon junction, 5′UTR, 3′UTR of all the genes of interest and the known regulatory regions of <em>BRCA1</em> and <em>BRCA2</em>. However, the position of the probes managed to cover additional regions which led us to identify another nine variants in intronic regions (all with a coverage ≥ 50X) that proved to be interesting for the predictions obtained by ‘TFbind’ and ‘Promo’ software and for the information obtained from rVarBase and ENCODE (<a href="#app1-ijms-22-07693" class="usa-link">Table S2e/Supplementary Materials</a>). Two variants are in the intron 61 of <em>ATM</em>, one in the intron 16 of <em>BRIP1</em>, two in intron 2 respectively of <em>RAD51C</em> and <em>RAD51D</em> genes and four variants are in the intron 1 of <em>TP53</em>. Eight out of nine variants are classified as VUS and four are not registered in dbSNP. </p></section><section id="sec2dot6-ijms-22-07693"><h3 class="pmc_sec_title">2.6. Demographics and Clinical Features of Patiens with Non-Coding Variants</h3>
<p>Non-coding variants were found in 64 patients (excluding two cases of co-occurrence of Pathogenic coding variants). According to this data, in these patients there is a significant increase in both ovarian cancer (χ2-test, <em>p</em> &lt; 0.05) and HBOC families (χ2-test, <em>p</em> &lt; 0.01), compared to patients with variants in coding regions (<a href="#ijms-22-07693-t001" class="usa-link">Table 1</a>/<a href="#ijms-22-07693-t004" class="usa-link">Table 4</a>).</p>
<section class="tw xbox font-sm" id="ijms-22-07693-t004"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>Non-coding variant carrier characteristics: percentage distribution of probands according to cancer type and cancer family history. The number of patients is shown in brackets. The average age at disease onset is reported for each proband cancer type (for patients with bilateral breast cancer and multiple tumors, the age of onset of initial tumor has been considered).</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Non-Coding Variant Carrier Characteristics</th></tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patient number</td>
<td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">64</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Average age of cancer onset</td>
<td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">44.4</td>
</tr>
<tr>
<td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<strong>Proband cancer kind</strong>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Average age at onset</strong>
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast cancer</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67.2% (43)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43.9</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bilateral Breast Cancer</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.9% (7)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43.1</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ovarian cancer</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.7% (12)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast and ovarian cancer</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.6% (1)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast/Ovarian Cancer and other tumors </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.6% (1)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49</td>
</tr>
<tr><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<strong>Proband cancer history</strong>
</td></tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HBC</td>
<td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">53.1% (34)</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HBOC</td>
<td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">29.7% (19)</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EOBC</td>
<td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">4.7% (3)</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Other HBCS</td>
<td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">12.5% (8)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/ijms-22-07693-t004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>The mean age of tumor onset for these patients is 44.4. If we compare the coding and non-coding variant carriers in each proband group with the same kind of cancer, the average age of disease onset is completely comparable (<a href="#ijms-22-07693-t001" class="usa-link">Table 1</a>/<a href="#ijms-22-07693-t004" class="usa-link">Table 4</a>). In particular, if we compare the 64 non-coding variant carriers to the 39 Pathogenic coding variant carriers, there is not a statistically significant difference in the proportion of cases with a tumor onset under age 40 (<a href="#ijms-22-07693-t005" class="usa-link">Table 5</a>, χ2-test, <em>p</em> &gt; 0.05).</p>
<section class="tw xbox font-sm" id="ijms-22-07693-t005"><h4 class="obj_head">Table 5.</h4>
<div class="caption p"><p>Age of tumor onset: comparison between Pathogenic coding variant carriers and non-coding variant carriers.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pathogenic Coding Variant Carriers</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Non-Coding Variant Carriers</th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">≤40</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&gt;40</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/ijms-22-07693-t005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p><a href="#ijms-22-07693-f005" class="usa-link">Figure 5</a> shows the distribution by gene and by gene location of the variants identified respectively in 43 patients with BC, in 12 patients with ovarian cancer, and in 9 cases of patients with multiple tumors (seven with bilateral cancer, one with breast and ovarian cancer, and one with breast and pancreatic cancer). From this data emerges the high frequency of variants identified in the <em>ATM</em> gene, as well as in <em>BRCA1</em> and <em>BRCA2</em>, in patients with BC and the high contribution of variants localized in the 3′UTR of <em>PTEN</em> in patients with multiple tumors. In particular, three out of nine variants found in these patients are localized in <em>PTEN</em> 3′UTR and the bioinformatics predictions found, for all three, consensus sequences compatible with miRNA binding sites (<a href="#ijms-22-07693-f005" class="usa-link">Figure 5</a>, <a href="#app1-ijms-22-07693" class="usa-link">Table S2b/Supplementary Materials</a>). In patients with ovarian cancer, instead, variants were identified mainly in the <em>RAD50</em> and <em>RAD51C</em> genes.</p>
<figure class="fig xbox font-sm" id="ijms-22-07693-f005"><h4 class="obj_head">Figure 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8305371_ijms-22-07693-g005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f77/8305371/cc75a53ab758/ijms-22-07693-g005.jpg" loading="lazy" height="606" width="764" alt="Figure 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/ijms-22-07693-f005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Variant distribution by gene and by gene region (5′UTR, 3′UTR, Splice regions and Intron regions) respectively in patients with breast cancer (<strong>a</strong>), ovarian cancer (<strong>b</strong>), and with multiple tumors (<strong>c</strong>).</p></figcaption></figure><p>Among the 12 cases of TNBC, all with G2 or G3 infiltrating ductal carcinoma, 4 variants out of 19 identified are on the <em>PTEN</em> gene: one located at 5′UTR and the others at 3′UTR. Other interesting variants, for the type of feedback we obtained through prediction analysis, are the variants in the 5′UTR of <em>RAD51D</em> and <em>STK11</em> genes. The complete list of variants found in these patients is shown in <a href="#ijms-22-07693-t006" class="usa-link">Table 6</a>. Four variants are in intronic regions of <em>BRCA2</em>. Furthermore, among all the non-coding variants filtered in this work, the only variant in the <em>RAD51C</em> gene classified as “Pathogenic” by ACMG criteria was found in one of these patients. </p>
<section class="tw xbox font-sm" id="ijms-22-07693-t006"><h4 class="obj_head">Table 6.</h4>
<div class="caption p"><p>Variants identified in the 12 patients with TNBC among the non-coding-variant carriers. The table shows the variant position in the gene (ss = splice site), the clinical classification (P = Pathogenic, VUS = Variant of Unknown clinical Significance, B = Benign), the frequency of each variant and any database registration. The variants are reported in HGVS nomenclature and those highlighted with the same color belong to the same patient.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr><th colspan="7" align="center" valign="middle" style="border-top:solid thin" rowspan="1">Variants in 12 Cases of TNBC</th></tr>
<tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Variant</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Position</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Classification</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Patient</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">dbSNP</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Database</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">c.-323C &gt; T</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">PTEN</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">5’UTR</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">Varese 36</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">c.-116C &gt; T</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">RAD51D</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">5’UTR</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">Varese 36</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1"> c.*1122_*1123insT </td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">PTEN</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">3’UTR</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">Varese 36</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">c.9257-3610G &gt; A </td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">BRCA2</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">Intron 24</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">Varese 36</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">rs17077519|</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#92D050" rowspan="1" colspan="1">BRCAexchange</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC000" rowspan="1" colspan="1">c.-239C &gt; T </td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC000" rowspan="1" colspan="1">RAD51D</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC000" rowspan="1" colspan="1">5’UTR</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC000" rowspan="1" colspan="1">LB</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC000" rowspan="1" colspan="1">Varese 55</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC000" rowspan="1" colspan="1">rs550346401</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC000" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC000" rowspan="1" colspan="1">c.681+697C &gt; T </td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC000" rowspan="1" colspan="1">BRCA2</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC000" rowspan="1" colspan="1">Intron 8</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC000" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC000" rowspan="1" colspan="1">Varese 55</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC000" rowspan="1" colspan="1">rs11571632</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC000" rowspan="1" colspan="1">BRCAexchange</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#00B0F0" rowspan="1" colspan="1">c.-636C &gt; T </td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#00B0F0" rowspan="1" colspan="1">STK11</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#00B0F0" rowspan="1" colspan="1">5’UTR</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#00B0F0" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#00B0F0" rowspan="1" colspan="1">Pisa 1489</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#00B0F0" rowspan="1" colspan="1">rs981125953</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#00B0F0" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#00B0F0" rowspan="1" colspan="1">c.*1674 &gt; G </td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#00B0F0" rowspan="1" colspan="1">RAD50</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#00B0F0" rowspan="1" colspan="1">3’UTR</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#00B0F0" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#00B0F0" rowspan="1" colspan="1">Pisa 1489</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#00B0F0" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#00B0F0" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.*26A &gt; G </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3’UTR</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pisa 2348</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs1247328981</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.*724dupT </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NBN</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3’UTR</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Varese 10</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs564878448</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.*4606_*4609delGCTT </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PTEN</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3’UTR</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bari 1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.*1152C &gt; T </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PTEN</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3’UTR</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Varese 17</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs552354954</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#8EA9DB" rowspan="1" colspan="1">c.7788+8G &gt; T </td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#8EA9DB" rowspan="1" colspan="1">ATM</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#8EA9DB" rowspan="1" colspan="1">Intron 52ss</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#8EA9DB" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#8EA9DB" rowspan="1" colspan="1">Bari 4</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#8EA9DB" rowspan="1" colspan="1">rs112775908</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#8EA9DB" rowspan="1" colspan="1">LOVD</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#8EA9DB" rowspan="1" colspan="1">c.317-1021A &gt; G</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#8EA9DB" rowspan="1" colspan="1">BRCA2</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#8EA9DB" rowspan="1" colspan="1">Intron 3</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#8EA9DB" rowspan="1" colspan="1">VUS </td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#8EA9DB" rowspan="1" colspan="1">Bari 4</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#8EA9DB" rowspan="1" colspan="1">rs11571604</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:#8EA9DB" rowspan="1" colspan="1">BRCAexchange</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin;background:yellow" rowspan="1" colspan="1">c.8850+389G &gt; A </td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:yellow" rowspan="1" colspan="1">ATM</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:yellow" rowspan="1" colspan="1">Intron 61</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:yellow" rowspan="1" colspan="1">LB</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:yellow" rowspan="1" colspan="1">Varese 14</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:yellow" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:yellow" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin;background:yellow" rowspan="1" colspan="1">c.317-512A &gt; T </td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:yellow" rowspan="1" colspan="1">BRCA2</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:yellow" rowspan="1" colspan="1">Intron 3</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:yellow" rowspan="1" colspan="1">VUS </td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:yellow" rowspan="1" colspan="1">Varese 14</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:yellow" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin;background:yellow" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.320-5T &gt; C </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CHEK2</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intron 24ss</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pisa 2280</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LOVD</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.904+5G &gt; T </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RAD51C</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intron 6ss</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pisa 1564</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs587782702</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LOVD</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.-29+475C &gt; A </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TP53</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intron 1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VUS </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Varese 20</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/ijms-22-07693-t006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Twelve patients with multiple variants in non-coding regions were filtered to assess whether the presence of multiple mutations could affect tumor pathogenicity. Ten out of 12 filtered patients have BC and 6 of these have TNBC. According to our data, there is a statistically significant association between TNBC and multiple variants in non-coding regions (χ2-test, <em>p</em> &lt; 0.05). In fact, 50% of BC patients with multiple variants in non-coding regions have TNBC, while, among the 52 BC non-coding variants carriers, only 12 (23.1%) have TNBC (χ2-test, <em>p</em> &lt; 0.05; <a href="#ijms-22-07693-t007" class="usa-link">Table 7</a>).</p>
<section class="tw xbox font-sm" id="ijms-22-07693-t007"><h4 class="obj_head">Table 7.</h4>
<div class="caption p"><p>Patients with multiple non-coding variants, age at disease diagnosis and tumor characteristics. The table also reports the cases of co-occurrence of VUS and Likely-benign coding variants with multiple non-coding variants in the same patient. The variants are reported in HGVS nomenclature.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Patients</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Non-Coding Variants</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Coding Variants</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cancer</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Age at Diagnosis</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Histological Characteristics</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">TNBC</th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pisa 710</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.-1193C &gt; T BRCA2; c.-408T &gt; A BRCA1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">57</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">infiltrating ductal carcinoma</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pisa 1489</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.*1674A &gt; G RAD50; c.-636C &gt; T STK11</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">infiltrating ductal carcinoma</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">V</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bari 4</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.7788+8G &gt; T ATM, c.317-1021A &gt; G BRCA1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.2074G &gt; A CDH1, c.17_18insGCG PTEN</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">infiltrating ductal carcinoma</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">V</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Varese 7</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.-138G &gt; C PALB2, c.-29+622G &gt; C TP53</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1094G &gt; A RAD50</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ovary</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">serous carcinoma</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Varese 8</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.81-4100A &gt; C BRCA1, c.*114A &gt; G RAD50</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.4060C &gt; A ATM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">infiltrating ductal carcinoma</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Varese 14</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.8850+389G &gt; A ATM, c.317-512A &gt; T BRCA2</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">infiltrating ductal carcinoma</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">V</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Varese 36</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.9257-3610G&gt;A BRCA2, c.-323C &gt; T PTEN, c.*1122_*1123insT PTEN, c.-116C &gt; T RAD51D</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">infiltrating ductal carcinoma</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">V</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Varese 43</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.560+19_560+22delTACT ATM, c.904+5G &gt; T RAD51C</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ovary</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">serous carcinoma</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Varese 45</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.*2842A &gt; G ATM, c.*750A &gt; G BRCA1, c.*106G &gt; A RAD51D</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1810C &gt; T ATM, c.6226A &gt; G ATM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">infiltrating ductal carcinoma</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Varese 51</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.8850+689A &gt; C ATM, c.*537A &gt; C ATM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">infiltrating ductal carcinoma</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Varese 55</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.681+697C &gt; T BRCA2,c.-239C &gt; T RAD51D</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1810C &gt; T ATM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">infiltrating ductal carcinoma</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">V</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pisa 2582</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.-24A&gt;C ATM, c.*261C&gt;T STK11</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bil.Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">infiltrating ductal carcinoma</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/ijms-22-07693-t007/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section></section><section id="sec3-ijms-22-07693"><h2 class="pmc_sec_title">3. Discussion</h2>
<p>This study regards the analysis of coding regions and 50 bp flanking intron–exon junction of 10 BC predisposition genes in a cohort of 450 HBOC patients. For a portion of these patients (120) the screening was extended to additional two genes (<em>NBN</em> and <em>RAD50</em>), to the 5′UTR and 3′UTR of each gene analyzed and to the known regulatory regions of <em>BRCA1</em> and <em>BRCA2</em>.Eighty eight coding variants were identified in 91/450 patients (20.2%): 35 of these were classified as pathogenic (class 5) or likely-pathogenic (class 4) and found in 39 patients (8.7%), 37 were classified as VUSs in 41 patients (9.1%) and 16 as “Likely-benign” in 19 patients (4.2%).</p>
<p><em>ATM</em> was the more mutated gene (16 carriers), followed by <em>CHEK2</em> (8 carriers), <em>BRIP1</em> (7 carriers), <em>PALB2</em> (3 carriers). <em>RAD51C</em> and <em>RAD51D</em> were found mutated in 2 patients/each and <em>TP53</em> in one patient only.</p>
<p>Thirteen variants in the intron-exon junctions were identified in 23/450 patients (5.1%) and 51 non-coding variants in 39 out of 120 patients analyzed for this purpose (32.5%).</p>
<p>Our results support what was recently published by the Breast Cancer Association Consortium in a larger and more geographically heterogeneous population consisting of 60,466 women. With a panel of 34 putative susceptibility genes, a significant association between the increased risk of breast cancer and truncating mutations in <em>ATM</em>, <em>CHEK2</em>, <em>PALB2</em>, <em>BARD1</em>, <em>RAD51C</em>, <em>RAD51D</em>, and <em>TP53</em> was identified [<a href="#B27-ijms-22-07693" class="usa-link" aria-describedby="B27-ijms-22-07693">27</a>]. Similar results were found through a screening of 65,057 white woman with breast cancer where a high or moderately increased risk of disease was found in relation with pathogenic mutations in <em>ATM</em>, <em>CHEK2</em>, <em>PALB2</em>, and <em>RAD51D</em> [<a href="#B28-ijms-22-07693" class="usa-link" aria-describedby="B28-ijms-22-07693">28</a>].</p>
<p><em>ATM</em>, <em>CHEK2</em>, <em>PALB2</em>, and <em>TP53</em> were confirmed as breast cancer predisposition genes also by the German Consortium for Hereditary Breast and Ovarian Cancer, through a screening of eight cancer predisposition genes conducted on 5589 breast cancer patients negative for pathogenic <em>BRCA1/2</em> mutations [<a href="#B29-ijms-22-07693" class="usa-link" aria-describedby="B29-ijms-22-07693">29</a>]. An American retrospective study performed on 35,000 women who underwent genetic testing through a 25-gene hereditary cancer panel found the same correlation [<a href="#B30-ijms-22-07693" class="usa-link" aria-describedby="B30-ijms-22-07693">30</a>].</p>
<p>The analysis of non-coding regions reports a consistent number of variants never registered previously (18/64 variants). </p>
<p>In details, in the 5′UTR 2 variants were found, one in <em>BRCA1</em> (c.-676t &gt; a) and one in <em>BRCA2</em> (c.-1193c &gt; t). Both were registered in BRCA-exchange and LOVD database as VUSs. The in-silico analysis, conducted by ‘TFbind’ and ‘Promo Prediction’, has identified putative consensus sequences for Elk-1, NF-AT1, STAT4 transcription factors, for the first variant, and NRF2, GATA1/2, USF for the second. </p>
<p>Whereas the 5′UTR and 3′UTR of the <em>BRCA1/2</em> genes have been two of the most intensely investigated non–coding regions over the last few years [<a href="#B12-ijms-22-07693" class="usa-link" aria-describedby="B12-ijms-22-07693">12</a>,<a href="#B13-ijms-22-07693" class="usa-link" aria-describedby="B13-ijms-22-07693">13</a>,<a href="#B31-ijms-22-07693" class="usa-link" aria-describedby="B31-ijms-22-07693">31</a>,<a href="#B32-ijms-22-07693" class="usa-link" aria-describedby="B32-ijms-22-07693">32</a>,<a href="#B33-ijms-22-07693" class="usa-link" aria-describedby="B33-ijms-22-07693">33</a>,<a href="#B34-ijms-22-07693" class="usa-link" aria-describedby="B34-ijms-22-07693">34</a>], this is the first fully comprehensive study of 5′and 3′UTRs of so called “minor genes for breast/ovarian cancer susceptibility” and a number of variants were also identified in the 5′UTRs: 4 in the <em>PTEN</em> gene and 3 in the <em>RAD51C</em> gene and the in-silico predictions obtained regarding their involvement in TF binding are interesting (<a href="#app1-ijms-22-07693" class="usa-link">Table S2a in Supplementary Materials</a>).</p>
<p>In the 3′UTRs of genes other than BRCA1/2, the greatest contribution was due to variants located in the <em>ATM</em> (5), <em>PTEN</em> (7) and <em>RAD50</em> (4) genes. The use of software such as ‘TargetScanHuman’ and ‘miRDB’ has made it possible to identify in those regions binding sites for miRNAs (<a href="#app1-ijms-22-07693" class="usa-link">Table S2b in Supplementary Materials</a>).</p>
<p>The variants localized in splice regions mainly affect the <em>ATM</em> (3) gene and, in particular the c.7788+8G &gt;T variant, localized in intron 52 of <em>ATM</em>, could modify an exonic ESE site (<a href="#app1-ijms-22-07693" class="usa-link">Table S2c in Supplementary Materials</a>). Another variant of interest is the c.904+5G &gt;T of <em>RAD51C</em>, classified by ACMG criteria as ‘Pathogenic’. </p>
<p>According to our data, variants in the intronic regions have been identified mainly in the <em>BRCA1</em> (5), <em>BRCA2</em> (7), <em>ATM</em> (2), and <em>RAD50</em> (2) genes. </p>
<p>Four out of 5 <em>BRCA1</em> variants are localized in intron 2 (c.81-3510_81-3505delCTTTTT; c.81-3790G &gt; C; c.81-4100A &gt; C; c.80+247C &gt; T) and the in-silico predictive analysis led us to identify TF binding sites in those regions (<a href="#app1-ijms-22-07693" class="usa-link">Table S2d/Supplementary Materials</a>). Those variants deserve to be studied in depth through a functional assay because in <em>BRCA1</em> intron 2, two conserved enhancer regions (CNS1 and CNS2) are localized and involved in the regulation of gene expression [<a href="#B26-ijms-22-07693" class="usa-link" aria-describedby="B26-ijms-22-07693">26</a>].</p>
<p>Eleven out of 12 intronic variants found in <em>BRCA1/2</em> genes could be classified as ‘deep intronic’. The deep intronic regions of the BRCA genes are intensely been studied in the recent years. These investigations have led to the identification of variants capable to modify the expression level or the functionality of the BRCA1 protein [<a href="#B35-ijms-22-07693" class="usa-link" aria-describedby="B35-ijms-22-07693">35</a>].</p>
<p>Finally, we incidentally found two new variants in deep intronic regions of the <em>ATM</em> and <em>TP53</em> genes in two patients with TNBC (due to the fact that additional regions that were not of our interest were included in the panel design). The variants are respectively in intron 61 of <em>ATM</em> (c.8850+389G &gt; A) and intron 1 of <em>TP53</em>(c.-29+475C &gt; A) and are both predicted as TF binding regions. This result underlines how important is to broaden screening to deeper intronic regions (not only in BRCA genes).</p>
<p>By analyzing the characteristics of patients for the type of variants identified, distinguishing between coding variant carriers versus non-coding variant carriers, we can make some interesting considerations.</p>
<p>The average age of breast cancer onset in coding variants carriers is 44 and most of them have breast cancer only family history as shown in <a href="#ijms-22-07693-t001" class="usa-link">Table 1</a>.</p>
<p>A possible association of <em>ATM-BRIP1-PALB2</em> and a significant association of <em>CHEK2</em> pathogenic/likely-pathogenic coding variants with multiple tumors, including bilateral breast cancer, was observed. These data are in agreement with the findings of German Consortium for Hereditary Breast and Ovarian Cancer, that demonstrated a significant association of <em>CHEK2</em> deleterious variants with bilateral breast cancer [<a href="#B29-ijms-22-07693" class="usa-link" aria-describedby="B29-ijms-22-07693">29</a>].</p>
<p>Among the 12 cases of TNBC patients, 6 were carriers of pathogenic coding variants: 2 in <em>CHEK2</em> and the remaining 4 in the <em>ATM</em>, <em>BRIP1</em>, <em>RAD51D</em> and <em>TP53</em> genes respectively (<a href="#ijms-22-07693-t003" class="usa-link">Table 3</a>).</p>
<p>Studies conducted on a larger number of TNBC patients have come to concordant results regarding the association of these cases with pathogenic variants in the <em>PALB2</em>, <em>BRIP1</em>, <em>RAD51C</em>, and <em>RAD51D</em> genes [<a href="#B30-ijms-22-07693" class="usa-link" aria-describedby="B30-ijms-22-07693">30</a>,<a href="#B36-ijms-22-07693" class="usa-link" aria-describedby="B36-ijms-22-07693">36</a>,<a href="#B37-ijms-22-07693" class="usa-link" aria-describedby="B37-ijms-22-07693">37</a>,<a href="#B38-ijms-22-07693" class="usa-link" aria-describedby="B38-ijms-22-07693">38</a>]. Our results partially agree with these data, having identified pathogenic variants in TNBC patients with <em>ATM</em>, <em>RAD51D</em>, <em>BRIP1</em>, and <em>TP53</em> variants. It is likely that the analysis of a higher number of TNBC cases could have led us to a greater degree of concordance. </p>
<p>However, it is certainly very interesting that 50% of the TNBC cases analyzed had pathogenic coding variants: it is a higher proportion compared to that obtained in other cohorts of TNBC patients filtered in the population solely on the basis of their tumor phenotype [<a href="#B36-ijms-22-07693" class="usa-link" aria-describedby="B36-ijms-22-07693">36</a>,<a href="#B37-ijms-22-07693" class="usa-link" aria-describedby="B37-ijms-22-07693">37</a>]. It is probable that the higher percentage registered in our cases depends on the double filtering, based not only on patient tumor phenotype but also on the patient breast cancer family history. </p>
<p>It is known that some TNBCs BRCAWT show the so-called ‘BRCAness’ phenotype, exhibiting clinical and pathological properties similar to BRCA-mutated tumors such as the homologous recombination deficiency and the sensitivity to DNA damaging agents [<a href="#B39-ijms-22-07693" class="usa-link" aria-describedby="B39-ijms-22-07693">39</a>,<a href="#B40-ijms-22-07693" class="usa-link" aria-describedby="B40-ijms-22-07693">40</a>]. Therefore, our data could be of interest at a therapeutic level. In fact, the data supports what we have already reported in Spugnesi et al. [<a href="#B38-ijms-22-07693" class="usa-link" aria-describedby="B38-ijms-22-07693">38</a>] where germline mutations in DNA repair genes, in BRCA1/2 WT tumors, were associated with a group of TNBC patients who responded to anthracyclines/taxanes neoadjuvant therapy. It is becoming increasingly evident that genes involved in DNA repair could become response biomarkers for DNA-damaging therapy in these patients [<a href="#B41-ijms-22-07693" class="usa-link" aria-describedby="B41-ijms-22-07693">41</a>].</p>
<p>Although we cannot make any consideration about the variants identified in ovarian cancer, having only analyzed four patients with ovarian cancer and two with breast and ovarian cancer, the detection of pathogenic variants in <em>RAD51C</em> and <em>ATM</em> is in agreement with what is reported in a case-control study performed on 2051 women with ovarian cancer. The authors of this paper identified an increased risk for ovarian cancer associated with <em>MSH6</em>, <em>RAD51C</em>, <em>TP53</em>, and <em>ATM</em> [<a href="#B42-ijms-22-07693" class="usa-link" aria-describedby="B42-ijms-22-07693">42</a>].</p>
<p>Analyzing the characteristics of non-coding variants carriers, we recorded an average age of disease onset of 44.4 absolutely similar to the average age of disease onset in coding variant carriers for each proband’s group with the same cancer type. Furthermore, there is not a statistically significant difference in the proportion of cases with a tumor onset under the age of 40 between the two groups (χ2-test, <em>p</em> &gt; 0.05; <a href="#ijms-22-07693-t005" class="usa-link">Table 5</a>).</p>
<p>A statistically significant increase in cases of ovarian cancer and of HBOC families in non-coding variant carriers compared to coding variant carriers was found (<a href="#ijms-22-07693-t001" class="usa-link">Table 1</a>/<a href="#ijms-22-07693-t004" class="usa-link">Table 4</a>). This is an interesting observation but very preliminary considering the limited number of samples analyzed, and it needs to be further investigated.</p>
<p>One of the results that emerges clearly when analyzing the characteristics of non-coding variant carriers, is the relationship between variants in 3′UTR of <em>PTEN</em> and multiple tumors or TNBC tumor phenotype. This result is in agreement with what has already been described in previous studies in which the deregulation of <em>PTEN</em> expression, via binding sites for RNA-binding-protein and miRNA located in 3′UTR, was associated with aggressive phenotype and poor outcome for BC patients [<a href="#B16-ijms-22-07693" class="usa-link" aria-describedby="B16-ijms-22-07693">16</a>,<a href="#B17-ijms-22-07693" class="usa-link" aria-describedby="B17-ijms-22-07693">17</a>]. Moreover, four out of seven <em>BRCA2</em> deep intronic variants identified (c.9257-3610G &gt; A, c.681+697C &gt; T, c.317-1021A &gt; G, c.317-512A &gt; T) have been found in TNBC patients.</p>
<p>Finally, by analyzing the 12 patients carrying multiple non-coding variants we observed a statistically significant association with a TNBC phenotype (χ2-test, <em>p</em> &lt; 0.05).</p>
<p>This work has the merit of having highlighted certain variants never recorded in the coding and regulatory regions which are worthy of further study. It also underlines the importance, increasingly evident in recent years, of also screening the regulatory regions in patients with clearly familial tumors with no relevant variation in the coding sequences of the main breast/ovarian cancer predisposition genes. Certainly, in the future it will be necessary to perform a segregation analysis in order to understand the real involvement of certain genomic regions in breast and ovarian cancer predisposition. This work surely could help to pave the way for other in-depth projects on the functional meaning of the variants identified, by providing, thanks to the many notes obtained, a lot of useful information for a better understanding of their clinical significance.</p></section><section id="sec4-ijms-22-07693"><h2 class="pmc_sec_title">4. Materials and Methods</h2>
<section id="sec4dot1-ijms-22-07693"><h3 class="pmc_sec_title">4.1. Selection of Patients Included in the Study</h3>
<p>We selected a total of 450 patients eligible for this study who underwent genetic counseling between 2001 and 2019 at five different Italian centers distributed as follows:</p>
<ul class="list" style="list-style-type:none">
<li>
<span class="label">-</span><p class="display-inline">163 patients from University Hospital of Pisa</p>
</li>
<li>
<span class="label">-</span><p class="display-inline">210 patients from Azienda Tutela Salute Sardegna, ASST of Cagliari</p>
</li>
<li>
<span class="label">-</span><p class="display-inline">55 patients from Ospedale di Circolo, ASST-Sette Laghi of Varese</p>
</li>
<li>
<span class="label">-</span><p class="display-inline">13 patients from University Hospital of Modena</p>
</li>
<li>
<span class="label">-</span><p class="display-inline">9 patients from IRCCS Istituto Tumori “Giovanni Paolo II” of Bari</p>
</li>
</ul>
<p>All patients signed an informed consent. The eligibility criteria included:</p>
<ul class="list" style="list-style-type:none">
<li>
<span class="label">-</span><p class="display-inline">family history of BC in at least two generations: (a) two or more BC cases in first degree relatives, one of which diagnosed before age 40 (b) one ovarian cancer case associated with a BC in a first degree relative at any age;</p>
</li>
<li>
<span class="label">-</span><p class="display-inline">a priori risk of being carriers of BRCA1/2 mutation &gt;10% calculated with BRCAPRO (http//www4.utsouthwestern.edu/breast-health/cagene, accessed on March 2017–December 2019 ) and BOADICEA (<a href="https://pluto.srl.cam.ac.uk/cgi-bin/BD2/v2/bd.cgi" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pluto.srl.cam.ac.uk/cgi-bin/BD2/v2/bd.cgi</a>, accessed on March 2017–December 2019) software;</p>
</li>
<li>
<span class="label">-</span><p class="display-inline">to be wild type for point mutations and large rearrangements in the BRCA1/2 coding regions.</p>
</li>
</ul></section><section id="sec4dot2-ijms-22-07693"><h3 class="pmc_sec_title">4.2. Library Preparation and NGS Sequencing</h3>
<p>DNA was extracted from blood samples. Genomic DNA screening was carried out with a NGS target resequencing approach on the Illumina MiSeq machine. 450 patients were analyzed with a custom panel optimized to sequence the coding regions and 50 bp flanking each intron-exon junction of 10 genes involved in breast and ovarian cancer predisposition: <em>ATM</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000051.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000051.3</a>), BRIP1 (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_032043.2" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_032043.2</a>), <em>CDH1</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_004360.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_004360.3</a>), <em>CHECK2</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007194.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007194.3</a>), <em>PALB2</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_024675.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_024675.3</a>), <em>PTEN</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000314.6" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000314.6</a>), <em>RAD51C</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_058216.2" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_058216.2</a>), <em>RAD51D</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_002878.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_002878.3</a>), <em>STK11</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000455.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000455.4</a>), <em>TP53</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000546.5" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000546.5</a>). For a subset of 120 patients (43 from Pisa, 55 from Varese, 13 from Modena and 9 from Bari), the screening was also extended to <em>NBN</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_002485.5" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_002485.5</a>) and <em>RAD50</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005732" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_005732</a>) genes, including 5′UTR and 3′UTR of each gene and the known regulatory regions of <em>BRCA1</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>) and <em>BRCA2</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059</a>) [<a href="#B12-ijms-22-07693" class="usa-link" aria-describedby="B12-ijms-22-07693">12</a>,<a href="#B13-ijms-22-07693" class="usa-link" aria-describedby="B13-ijms-22-07693">13</a>,<a href="#B14-ijms-22-07693" class="usa-link" aria-describedby="B14-ijms-22-07693">14</a>,<a href="#B15-ijms-22-07693" class="usa-link" aria-describedby="B15-ijms-22-07693">15</a>,<a href="#B26-ijms-22-07693" class="usa-link" aria-describedby="B26-ijms-22-07693">26</a>]. To amplify the target sequences, a panel of 9071 probes was designed using SureSelect DNA Advanced Design Wizard in order to ensure the total coverage of 178.155 kb corresponding to 99% of the entire region of interest (<a href="#app1-ijms-22-07693" class="usa-link">Supplementary Materials Table S2a,b</a>). Library preparation was performed according to SureSelectQXT Target Enrichment for Illumina Multiplexed Sequencing protocol (SureSelectQXT Reagent Kit, Agilent Technologies, Santa Clara, CA, USA). To assess library DNA quantity and quality after fragmentation and adaptor-tag addiction phase and after amplification of the indexed library, we used the Agilent 2100 Bioanalyzer. Following purification and quantification of pooled libraries, we sequenced them by 2 × 100 bp paired-end reads on a Miseq (Illumina, San Diego, CA, USA) instrument. Sequence reads allocated to each individual were aligned to the human reference sequence (hg19) using Agilent Sure Call (ver.4.1.1). All the regions considered for the analysis had a coverage ≥50X and a Quality Score (QS) ≥30. Sanger sequencing was performed to confirm the identified variants in lymphocyte DNA.</p></section><section id="sec4dot3-ijms-22-07693"><h3 class="pmc_sec_title">4.3. Bioinformatic Annotation and Prioritization of the Identified Variants</h3>
<p>Each identified variant was evaluated in terms of Minor Allele Frequency (MAF): reference allelic frequency is that of total population reported in 1000 Genomes (<a href="http://www.internationalgenome.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.internationalgenome.org</a>, accessed on January 2020) and in gnomAD (<a href="https://gnomad.broadinstitute.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://gnomad.broadinstitute.org</a>, accessed on January 2020). All variants with a MAF &gt;1% were excluded from further analysis as they were considered common polymorphisms. To speed up the reading of the variants and their filtering on the basis of the known annotations, we used BaseSpace Variant Interpreter platform (<a href="https://variantinterpreter.informatics.illumina.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://variantinterpreter.informatics.illumina.com</a>, accessed on January 2020). All variants were also evaluated in term of evolutionary conservation profile (GERP score) [<a href="#B43-ijms-22-07693" class="usa-link" aria-describedby="B43-ijms-22-07693">43</a>]. The clinical significance of each variant was annotated considering information from ClinVar (<a href="https://www.ncbi.nlm.nih.gov/clinvar" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/clinvar</a>, accessed on August 2020) [<a href="#B44-ijms-22-07693" class="usa-link" aria-describedby="B44-ijms-22-07693">44</a>] and according to ACMG (American College of Medical Genetics) criteria [<a href="#B19-ijms-22-07693" class="usa-link" aria-describedby="B19-ijms-22-07693">19</a>,<a href="#B45-ijms-22-07693" class="usa-link" aria-describedby="B45-ijms-22-07693">45</a>] also used by Varsome (<a href="https://varsome.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://varsome.com</a>, accessed on August 2020) [<a href="#B46-ijms-22-07693" class="usa-link" aria-describedby="B46-ijms-22-07693">46</a>]. The latter helped us mostly to summarize all the known information and the pathogenicity predictions of the identified variants. </p>
<p>For the coding variant, we annotated the possible impact of an amino acid substitution on the protein structure and function obtained by PolyPhen2 (<a href="http://genetics.bwh.harvard.edu/pph2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://genetics.bwh.harvard.edu/pph2</a>, accessed on May 2020) and PROVEAN (<a href="http://provean.jcvi.org/index.php" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://provean.jcvi.org/index.php</a>, accessed on May 2020) software [<a href="#B47-ijms-22-07693" class="usa-link" aria-describedby="B47-ijms-22-07693">47</a>,<a href="#B48-ijms-22-07693" class="usa-link" aria-describedby="B48-ijms-22-07693">48</a>]. For the non-coding variants, in order to obtain information about chromatin states of the surrounding regions, methylation and acetylation status and hypersensitivity to DNAseI, we used rVarBase (<a href="http://rv.psych.ac.cn" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://rv.psych.ac.cn</a>, accessed on February 2020) and ENCODE (<a href="https://www.encodeproject.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.encodeproject.org</a>, accessed on February 2020) database [<a href="#B49-ijms-22-07693" class="usa-link" aria-describedby="B49-ijms-22-07693">49</a>,<a href="#B50-ijms-22-07693" class="usa-link" aria-describedby="B50-ijms-22-07693">50</a>,<a href="#B51-ijms-22-07693" class="usa-link" aria-describedby="B51-ijms-22-07693">51</a>].</p>
<p>To predict possible TF binding site in 5′UTR and in intronic enhancer regions, we emploied three different software: Promo (<a href="http://alggen.lsi.upc.es/cgi-bin/promo_v3/promo/promoinit.cgi?dirDB=TF_8.3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://alggen.lsi.upc.es/cgi-bin/promo_v3/promo/promoinit.cgi?dirDB=TF_8.3</a>, accessed on February 2020) [<a href="#B52-ijms-22-07693" class="usa-link" aria-describedby="B52-ijms-22-07693">52</a>], Tfbind (<a href="http://tfbind.hgc.jp/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://tfbind.hgc.jp/</a>) and Lasagna-Search2.0 (<a href="https://biogrid-lasagna.engr.uconn.edu/lasagna_search/index.php" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://biogrid-lasagna.engr.uconn.edu/lasagna_search/index.php</a>, accessed on February 2020) [<a href="#B53-ijms-22-07693" class="usa-link" aria-describedby="B53-ijms-22-07693">53</a>]. The presence of miRNA binding site in 3′UTR variants, was evaluated by TargetScanHuman (<a href="http://www.targetscan.org/vert_72" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.targetscan.org/vert_72</a>, accessed on February 2020) and miRDB (<a href="http://www.mirdb.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.mirdb.org</a>, accessed on February 2020) [<a href="#B54-ijms-22-07693" class="usa-link" aria-describedby="B54-ijms-22-07693">54</a>,<a href="#B55-ijms-22-07693" class="usa-link" aria-describedby="B55-ijms-22-07693">55</a>]. Finally, in order to identify consensus regions for potential splice sites, we made use of Human Splicing Finder (<a href="http://www.umd.be/HSF" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.umd.be/HSF</a>, accessed on February 2020) [<a href="#B56-ijms-22-07693" class="usa-link" aria-describedby="B56-ijms-22-07693">56</a>]. All the programs used to obtain predictions about the variants found are free software and they are summarized in <a href="#ijms-22-07693-t008" class="usa-link">Table 8</a>.</p>
<section class="tw xbox font-sm" id="ijms-22-07693-t008"><h4 class="obj_head">Table 8.</h4>
<div class="caption p"><p>Tools used for variant analysis, annotations and prioritization.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Coding Variant Annotations </th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Non-Coding Variant Annotations</th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Variant information from human genomic data (Variant Interpreter, Varsome)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Variant information from human genomic data (Variant Interpreter, Varsome)</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Relationships among human variants and phenotypes, clinical significance (ClinVar, ACMG criteria-Varsome)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Regulatory annotations, chromatin states of the surrounding regions, methylation and acetylation status, hypersensitivity to the DNAseI (rVarBase, Encode)</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Possible impact of an amino acid substitution on the structure and function of a human protein (PholyPhen2, PROVEAN)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TF binding sites ( PromoPrediction, TF Bind, Lasagna)</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">miRNA binding sites (TargetScan Human, miRDB)</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Consensus regions for potential splice sites (Human Splicing Finder)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/ijms-22-07693-t008/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>All this information allowed us to have more complete annotations of the variants, making it possible to suggest future functional tests, especially those never reported in literature or in databases such as ENIGMA (<a href="https://enigmaconsortium.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://enigmaconsortium.org</a>, accessed on December 2020), BRCA Exchange (<a href="https://brcaexchange.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://brcaexchange.org</a>, accessed on December 2020), LOVD (<a href="https://www.lovd.nl" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.lovd.nl</a>, accessed on December 2020), MgeND (<a href="https://mgend.med.kyoto-u.ac.jp" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://mgend.med.kyoto-u.ac.jp</a>, accessed on December 2020), and ClinVar Miner (<a href="https://clinvarminer.genetics.utah.edu" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://clinvarminer.genetics.utah.edu</a>, accessed on December 2020). For each variant, the dbSNP (<a href="https://www.ncbi.nlm.nih.gov/snp" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/snp</a>, accessed on January 2021) encoding was also checked.</p></section><section id="sec4dot4-ijms-22-07693"><h3 class="pmc_sec_title">4.4. Statistical Analysis </h3>
<p>Tumor type percentages, family distribution, and age at diagnosis in coding and non-coding variant carriers were compared by χ2-test. <em>p</em> &lt; 0.05% was considered statistically significant. The same test was used to estimate the effect of Pathogenic, VUS, and Likely Benign variants on clinical characteristics of coding variant carriers and to evaluate the presence of multiple variants in more aggressive tumors in non-coding variant carriers. </p>
<p>The gene association with tumor aggressiveness was performed through the Fisher’s test. The results were considered significant with a threshold of <em>p</em> &lt; 0.05%. All analyses were performed with the free software Social Science Statistics (<a href="https://www.socscistatistics.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.socscistatistics.com</a>, accessed on January 2021).</p></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The authors would like to acknowledge all laboratory technicians of the Molecular Genetics Section AOUP.</p></section><section id="app1-ijms-22-07693" class="app"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<p>The following are available online at <a href="https://www.mdpi.com/article/10.3390/ijms22147693/s1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.mdpi.com/article/10.3390/ijms22147693/s1</a>. </p>
<section class="sm xbox font-sm" id="ijms-22-07693-s001"><div class="media p"><div class="caption">
<a href="/articles/instance/8305371/bin/ijms-22-07693-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (248.5KB, zip) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>Conceptualization, M.A.C. and A.G.; methodology, C.G., R.S., G.G., E.C., M.T., F.B., T.C., E.F., and C.C. (Cinzia Cosini); Software, C.G., P.A., and E.C.; Validation, C.G. and E.C.; Investigation C.V., F.S., L.B., S.T., M.G.T., E.T. (Enrico Tagliafico), L.C., I.C., C.C. (Caterina Congregati), M.M., M.P., B.P., and M.G.; Data curation, C.G., E.C., M.T., and P.A.; Writing—original draft preparation, C.G. and M.A.C.; Writing—review and editing S.T., M.G.T., E.T. (Enrico Tagliafico), E.T. (Elena Tenedini), L.C., I.C., and T.C.; Supervision, A.G. and M.A.C. All authors have read and agreed to the published version of the manuscript. </p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This research was funded by FONDAZIONE PISA, grant number no. 127/16 (Italy). </p></section><section id="notes3"><h2 class="pmc_sec_title">Institutional Review Board Statement</h2>
<p>The study was approved by Ethics Committee of Area Vasta Nord Ovest (CEAVNO-protocol code: 13616-date of approval: 10 October 2019).</p></section><section id="notes4"><h2 class="pmc_sec_title">Informed Consent Statement</h2>
<p>Informed consent was obtained from all subjects involved in the study.</p></section><section id="notes5"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflict of interest.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1"><p><strong>Publisher’s Note:</strong> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1-ijms-22-07693">
<span class="label">1.</span><cite>Torre L.A., Bray F., Siegel R.L., Ferlay J., Lortet-Tieulent J., Jemal A. Global cancer statistics, 2012. CA Cancer J. Clin. 2015;65:87–108. doi: 10.3322/caac.21262.</cite> [<a href="https://doi.org/10.3322/caac.21262" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25651787/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA%20Cancer%20J.%20Clin.&amp;title=Global%20cancer%20statistics,%202012&amp;author=L.A.%20Torre&amp;author=F.%20Bray&amp;author=R.L.%20Siegel&amp;author=J.%20Ferlay&amp;author=J.%20Lortet-Tieulent&amp;volume=65&amp;publication_year=2015&amp;pages=87-108&amp;pmid=25651787&amp;doi=10.3322/caac.21262&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2-ijms-22-07693">
<span class="label">2.</span><cite>Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492.</cite> [<a href="https://doi.org/10.3322/caac.21492" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30207593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA%20Cancer%20J.%20Clin.&amp;title=Global%20cancer%20statistics%202018:%20GLOBOCAN%20estimates%20of%20incidence%20and%20mortality%20worldwide%20for%2036%20cancers%20in%20185%20countries&amp;author=F.%20Bray&amp;author=J.%20Ferlay&amp;author=I.%20Soerjomataram&amp;author=R.L.%20Siegel&amp;author=L.A.%20Torre&amp;volume=68&amp;publication_year=2018&amp;pages=394-424&amp;pmid=30207593&amp;doi=10.3322/caac.21492&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3-ijms-22-07693">
<span class="label">3.</span><cite>Mavaddat N., Peock S., Frost D., Ellis S., Platte R., Fineberg E., Evans D.G., Izatt L., Eeles R.A., Adlard J., et al.  Cancer risks for BRCA1 and BRCA2 mutation carriers: Results from prospective analysis of EMBRACE. J. Nat. Cancer Inst. 2013;105:812–822. doi: 10.1093/jnci/djt095.</cite> [<a href="https://doi.org/10.1093/jnci/djt095" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23628597/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Nat.%20Cancer%20Inst.&amp;title=Cancer%20risks%20for%20BRCA1%20and%20BRCA2%20mutation%20carriers:%20Results%20from%20prospective%20analysis%20of%20EMBRACE&amp;author=N.%20Mavaddat&amp;author=S.%20Peock&amp;author=D.%20Frost&amp;author=S.%20Ellis&amp;author=R.%20Platte&amp;volume=105&amp;publication_year=2013&amp;pages=812-822&amp;pmid=23628597&amp;doi=10.1093/jnci/djt095&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4-ijms-22-07693">
<span class="label">4.</span><cite>Nielsen F.C., van Overeem Hansen T., Sorensen C.S. Hereditary breast and ovarian cancer: New genes in confined pathways. Nat. Rev. Cancer. 2016;16:599–612. doi: 10.1038/nrc.2016.72.</cite> [<a href="https://doi.org/10.1038/nrc.2016.72" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27515922/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Cancer&amp;title=Hereditary%20breast%20and%20ovarian%20cancer:%20New%20genes%20in%20confined%20pathways&amp;author=F.C.%20Nielsen&amp;author=T.%20van%20Overeem%20Hansen&amp;author=C.S.%20Sorensen&amp;volume=16&amp;publication_year=2016&amp;pages=599-612&amp;pmid=27515922&amp;doi=10.1038/nrc.2016.72&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5-ijms-22-07693">
<span class="label">5.</span><cite>Lord C.J., Ashworth A. BRCAness revisited. Nat. Rev. Cancer. 2016;16:110–120. doi: 10.1038/nrc.2015.21.</cite> [<a href="https://doi.org/10.1038/nrc.2015.21" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26775620/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Cancer&amp;title=BRCAness%20revisited&amp;author=C.J.%20Lord&amp;author=A.%20Ashworth&amp;volume=16&amp;publication_year=2016&amp;pages=110-120&amp;pmid=26775620&amp;doi=10.1038/nrc.2015.21&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6-ijms-22-07693">
<span class="label">6.</span><cite>Campeau P.M., Foulkes W.D., Tischkowitz M.D. Hereditary breast cancer: New genetic developments, new therapeutic avenues. Hum. Genet. 2008;124:31–42. doi: 10.1007/s00439-008-0529-1.</cite> [<a href="https://doi.org/10.1007/s00439-008-0529-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18575892/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Genet.&amp;title=Hereditary%20breast%20cancer:%20New%20genetic%20developments,%20new%20therapeutic%20avenues&amp;author=P.M.%20Campeau&amp;author=W.D.%20Foulkes&amp;author=M.D.%20Tischkowitz&amp;volume=124&amp;publication_year=2008&amp;pages=31-42&amp;pmid=18575892&amp;doi=10.1007/s00439-008-0529-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7-ijms-22-07693">
<span class="label">7.</span><cite>Antoniou A.C., Pharoah P.D., McMullan G., Day N.E., Ponder B.A., Easton D. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet. Epidemiol. 2001;21:1–18. doi: 10.1002/gepi.1014.</cite> [<a href="https://doi.org/10.1002/gepi.1014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11443730/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Epidemiol.&amp;title=Evidence%20for%20further%20breast%20cancer%20susceptibility%20genes%20in%20addition%20to%20BRCA1%20and%20BRCA2%20in%20a%20population-based%20study&amp;author=A.C.%20Antoniou&amp;author=P.D.%20Pharoah&amp;author=G.%20McMullan&amp;author=N.E.%20Day&amp;author=B.A.%20Ponder&amp;volume=21&amp;publication_year=2001&amp;pages=1-18&amp;pmid=11443730&amp;doi=10.1002/gepi.1014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8-ijms-22-07693">
<span class="label">8.</span><cite>Bonadona V., Lasset C. Inherited predisposition to breast cancer: After the BRCA1 and BRCA2 genes, what next? Bull. Cancer. 2003;90:587–594.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/12957799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bull.%20Cancer&amp;title=Inherited%20predisposition%20to%20breast%20cancer:%20After%20the%20BRCA1%20and%20BRCA2%20genes,%20what%20next?&amp;author=V.%20Bonadona&amp;author=C.%20Lasset&amp;volume=90&amp;publication_year=2003&amp;pages=587-594&amp;pmid=12957799&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9-ijms-22-07693">
<span class="label">9.</span><cite>Turnbull C., Rahman N. Genetic Predisposition to Breast Cancer: Past, Present, and Future. Hum. Genet. 2008;9:321–345. doi: 10.1146/annurev.genom.9.081307.164339.</cite> [<a href="https://doi.org/10.1146/annurev.genom.9.081307.164339" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18544032/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Genet.&amp;title=Genetic%20Predisposition%20to%20Breast%20Cancer:%20Past,%20Present,%20and%20Future&amp;author=C.%20Turnbull&amp;author=N.%20Rahman&amp;volume=9&amp;publication_year=2008&amp;pages=321-345&amp;pmid=18544032&amp;doi=10.1146/annurev.genom.9.081307.164339&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10-ijms-22-07693">
<span class="label">10.</span><cite>Diederichs S., Bartsch L., Berkmann J.C., Fröse K., Heitmann J., Hoppe C., Iggena D., Jazmati D., Karschnia P., Linsenmeier M., et al.  The dark matter of the cancer genome: Aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations. EMBO Mol. Med. 2016;8:442–457. doi: 10.15252/emmm.201506055.</cite> [<a href="https://doi.org/10.15252/emmm.201506055" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5126213/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26992833/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EMBO%20Mol.%20Med.&amp;title=The%20dark%20matter%20of%20the%20cancer%20genome:%20Aberrations%20in%20regulatory%20elements,%20untranslated%20regions,%20splice%20sites,%20non-coding%20RNA%20and%20synonymous%20mutations&amp;author=S.%20Diederichs&amp;author=L.%20Bartsch&amp;author=J.C.%20Berkmann&amp;author=K.%20Fr%C3%B6se&amp;author=J.%20Heitmann&amp;volume=8&amp;publication_year=2016&amp;pages=442-457&amp;pmid=26992833&amp;doi=10.15252/emmm.201506055&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11-ijms-22-07693">
<span class="label">11.</span><cite>De Siervi A., De Luca P., Byun J.S., Di L.J., Fufa T., Haggerty C.M., Vazquez E., Moiola C., Longo D.L., Gardner K. Transcriptional autoregulation by BRCA1. Cancer Res. 2010;70:532–542. doi: 10.1158/0008-5472.CAN-09-1477.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-09-1477" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2952428/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20068145/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&amp;title=Transcriptional%20autoregulation%20by%20BRCA1&amp;author=A.%20De%20Siervi&amp;author=P.%20De%20Luca&amp;author=J.S.%20Byun&amp;author=L.J.%20Di&amp;author=T.%20Fufa&amp;volume=70&amp;publication_year=2010&amp;pages=532-542&amp;pmid=20068145&amp;doi=10.1158/0008-5472.CAN-09-1477&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12-ijms-22-07693">
<span class="label">12.</span><cite>Wang J., Bian C., Li J., Couch F.J., Wu K., Zhao R.C. Poly(ADP-ribose) polymerase-1 down-regulates BRCA2 expression through the BRCA2 promoter. J. Biol. Chem. 2008;283:36249–36256. doi: 10.1074/jbc.M803693200.</cite> [<a href="https://doi.org/10.1074/jbc.M803693200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2605989/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18990703/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=Poly(ADP-ribose)%20polymerase-1%20down-regulates%20BRCA2%20expression%20through%20the%20BRCA2%20promoter&amp;author=J.%20Wang&amp;author=C.%20Bian&amp;author=J.%20Li&amp;author=F.J.%20Couch&amp;author=K.%20Wu&amp;volume=283&amp;publication_year=2008&amp;pages=36249-36256&amp;pmid=18990703&amp;doi=10.1074/jbc.M803693200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13-ijms-22-07693">
<span class="label">13.</span><cite>Burke L.J., Sevcik J., Gambino G., Tudini E., Mucaki E.J., Shirley B.C., Whiley P., Parsons M.T., Leeneer K.D., Gutiérrez-Enríquez S., et al.  BRCA1 and BRCA2 5’ noncoding region variants identified in breast cancer patients alter promoter activity and protein binding. Hum. Mutat. 2018;39:2025–2039. doi: 10.1002/humu.23652.</cite> [<a href="https://doi.org/10.1002/humu.23652" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6282814/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30204945/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=BRCA1%20and%20BRCA2%205%E2%80%99%20noncoding%20region%20variants%20identified%20in%20breast%20cancer%20patients%20alter%20promoter%20activity%20and%20protein%20binding&amp;author=L.J.%20Burke&amp;author=J.%20Sevcik&amp;author=G.%20Gambino&amp;author=E.%20Tudini&amp;author=E.J.%20Mucaki&amp;volume=39&amp;publication_year=2018&amp;pages=2025-2039&amp;pmid=30204945&amp;doi=10.1002/humu.23652&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14-ijms-22-07693">
<span class="label">14.</span><cite>Lheureux S., Lambert B., Krieger S., Legros A., Vaur D., Denoyelle C., Berthet P., Poulain L., Hardouin A. Two novel variants in the 3’UTR of the BRCA1 gene in familial breast and/or ovarian cancer. Breast Cancer Res. Treat. 2011;125:885–891. doi: 10.1007/s10549-010-1165-8.</cite> [<a href="https://doi.org/10.1007/s10549-010-1165-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20848184/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=Two%20novel%20variants%20in%20the%203%E2%80%99UTR%20of%20the%20BRCA1%20gene%20in%20familial%20breast%20and/or%20ovarian%20cancer&amp;author=S.%20Lheureux&amp;author=B.%20Lambert&amp;author=S.%20Krieger&amp;author=A.%20Legros&amp;author=D.%20Vaur&amp;volume=125&amp;publication_year=2011&amp;pages=885-891&amp;pmid=20848184&amp;doi=10.1007/s10549-010-1165-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15-ijms-22-07693">
<span class="label">15.</span><cite>Brewster B.L., Rossiello F., French J.D., Edwards S.L., Wong M., Wronski A., Whiley P., Waddell N., Chen X., Bove B., et al.  Identification of fifteen novel germline variants in the BRCA1 3’UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site. Hum. Mutat. 2012;33:1665–1675. doi: 10.1002/humu.22159.</cite> [<a href="https://doi.org/10.1002/humu.22159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22753153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Identification%20of%20fifteen%20novel%20germline%20variants%20in%20the%20BRCA1%203%E2%80%99UTR%20reveals%20a%20variant%20in%20a%20breast%20cancer%20case%20that%20introduces%20a%20functional%20miR-103%20target%20site&amp;author=B.L.%20Brewster&amp;author=F.%20Rossiello&amp;author=J.D.%20French&amp;author=S.L.%20Edwards&amp;author=M.%20Wong&amp;volume=33&amp;publication_year=2012&amp;pages=1665-1675&amp;pmid=22753153&amp;doi=10.1002/humu.22159&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16-ijms-22-07693">
<span class="label">16.</span><cite>Zhou X.J., Wu J., Shi L., Li X.-X., Zhu L., Sun X., Qian J.-Y., Wang Y., Wei J.-F., Ding Q. PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer. J. Exp. Clin. Cancer Res. 2017;36:149. doi: 10.1186/s13046-017-0620-3.</cite> [<a href="https://doi.org/10.1186/s13046-017-0620-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5649103/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29052531/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Exp.%20Clin.%20Cancer%20Res.&amp;title=PTEN%20expression%20is%20upregulated%20by%20a%20RNA-binding%20protein%20RBM38%20via%20enhancing%20its%20mRNA%20stability%20in%20breast%20cancer&amp;author=X.J.%20Zhou&amp;author=J.%20Wu&amp;author=L.%20Shi&amp;author=X.-X.%20Li&amp;author=L.%20Zhu&amp;volume=36&amp;publication_year=2017&amp;pages=149&amp;pmid=29052531&amp;doi=10.1186/s13046-017-0620-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17-ijms-22-07693">
<span class="label">17.</span><cite>Fang H., Xie J., Zhang M., Zhao Z., Wan Y., Yao Y. miRNA-21 promotes proliferation invasion of triple-negative breast cancer cells through targeting, P.T.E.N. Am. J. Transl. Res. 2017;9:953–961.</cite> [<a href="/articles/PMC5375989/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28386324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Transl.%20Res.&amp;title=miRNA-21%20promotes%20proliferation%20invasion%20of%20triple-negative%20breast%20cancer%20cells%20through%20targeting,%20P.T.E.N&amp;author=H.%20Fang&amp;author=J.%20Xie&amp;author=M.%20Zhang&amp;author=Z.%20Zhao&amp;author=Y.%20Wan&amp;volume=9&amp;publication_year=2017&amp;pages=953-961&amp;pmid=28386324&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18-ijms-22-07693">
<span class="label">18.</span><cite>Plon S.E., Eccles D.M., Easton D., Foulkes W.D., Genuardi M., Greenblatt M.S., Hogervorst F.B.L., Hoogerbrugge N., Spurdle A.B., Tavtigian S.V., et al.  Sequence variant classification and reporting: Recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum. Mutat. 2008;29:1282–1291. doi: 10.1002/humu.20880.</cite> [<a href="https://doi.org/10.1002/humu.20880" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3075918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18951446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Sequence%20variant%20classification%20and%20reporting:%20Recommendations%20for%20improving%20the%20interpretation%20of%20cancer%20susceptibility%20genetic%20test%20results&amp;author=S.E.%20Plon&amp;author=D.M.%20Eccles&amp;author=D.%20Easton&amp;author=W.D.%20Foulkes&amp;author=M.%20Genuardi&amp;volume=29&amp;publication_year=2008&amp;pages=1282-1291&amp;pmid=18951446&amp;doi=10.1002/humu.20880&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19-ijms-22-07693">
<span class="label">19.</span><cite>Tavtigian S.V., Greenblatt M.S., Harrison S.M., Nussbaum R.L., Prabhu S.A., Boucher K.M., Biesecker L.G. ClinGen Sequence Variant Interpretation Working Group. Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework. Genet. Med. 2018;20:1054–1060. doi: 10.1038/gim.2017.210.</cite> [<a href="https://doi.org/10.1038/gim.2017.210" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6336098/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29300386/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Med.&amp;title=ClinGen%20Sequence%20Variant%20Interpretation%20Working%20Group.%20Modeling%20the%20ACMG/AMP%20variant%20classification%20guidelines%20as%20a%20Bayesian%20classification%20framework&amp;author=S.V.%20Tavtigian&amp;author=M.S.%20Greenblatt&amp;author=S.M.%20Harrison&amp;author=R.L.%20Nussbaum&amp;author=S.A.%20Prabhu&amp;volume=20&amp;publication_year=2018&amp;pages=1054-1060&amp;pmid=29300386&amp;doi=10.1038/gim.2017.210&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20-ijms-22-07693">
<span class="label">20.</span><cite>Iversen E.S., Jr., Couch F.J., Goldgar D.E., Tavtigian S.V., Monteiro A.N. A computational method to classify variants of uncertain significance using functional assay data with application to BRCA1. Cancer Epidemiol. Biomark. Prev. 2001;20:1078–1088. doi: 10.1158/1055-9965.EPI-10-1214.</cite> [<a href="https://doi.org/10.1158/1055-9965.EPI-10-1214" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3111818/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21447777/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol.%20Biomark.%20Prev.&amp;title=A%20computational%20method%20to%20classify%20variants%20of%20uncertain%20significance%20using%20functional%20assay%20data%20with%20application%20to%20BRCA1&amp;author=E.S.%20Iversen&amp;author=F.J.%20Couch&amp;author=D.E.%20Goldgar&amp;author=S.V.%20Tavtigian&amp;author=A.N.%20Monteiro&amp;volume=20&amp;publication_year=2001&amp;pages=1078-1088&amp;pmid=21447777&amp;doi=10.1158/1055-9965.EPI-10-1214&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21-ijms-22-07693">
<span class="label">21.</span><cite>Parsons M.T., Tudini E., Li H., Hahnen E., Wappenschmidt B., Feliubadaló L., Aalfs C.M., Agata S., Aittomäki K., Alducci E., et al.  Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification. Hum. Mutat. 2019;40:1557–1578. doi: 10.1002/humu.23818.</cite> [<a href="https://doi.org/10.1002/humu.23818" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6772163/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31131967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Large%20scale%20multifactorial%20likelihood%20quantitative%20analysis%20of%20BRCA1%20and%20BRCA2%20variants:%20An%20ENIGMA%20resource%20to%20support%20clinical%20variant%20classification&amp;author=M.T.%20Parsons&amp;author=E.%20Tudini&amp;author=H.%20Li&amp;author=E.%20Hahnen&amp;author=B.%20Wappenschmidt&amp;volume=40&amp;publication_year=2019&amp;pages=1557-1578&amp;pmid=31131967&amp;doi=10.1002/humu.23818&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22-ijms-22-07693">
<span class="label">22.</span><cite>Millot G.A., Carvalho M.A., Caputo S.M., Vreeswijk M.P., Brown M.A., Webb M., Rouleau E., Neuhausen S.L., Hansen T.V.O., Galli A., et al.  A guide for functional analysis of BRCA1 variants of uncertain significance. Hum. Mutat. 2012;33:1526–1537. doi: 10.1002/humu.22150.</cite> [<a href="https://doi.org/10.1002/humu.22150" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3470782/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22753008/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=A%20guide%20for%20functional%20analysis%20of%20BRCA1%20variants%20of%20uncertain%20significance&amp;author=G.A.%20Millot&amp;author=M.A.%20Carvalho&amp;author=S.M.%20Caputo&amp;author=M.P.%20Vreeswijk&amp;author=M.A.%20Brown&amp;volume=33&amp;publication_year=2012&amp;pages=1526-1537&amp;pmid=22753008&amp;doi=10.1002/humu.22150&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23-ijms-22-07693">
<span class="label">23.</span><cite>Guidugli L., Carreira A., Caputo S.M., Ehlen A., Galli A., Monteiro A.N.A., Neuhausen S.L., Hansen T.V.O., Couch F.J., Vreeswijk M.P.G., et al.  Functional assays for analysis of variants of uncertain significance in BRCA2. Hum. Mutat. 2014;35:151–164. doi: 10.1002/humu.22478.</cite> [<a href="https://doi.org/10.1002/humu.22478" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3995136/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24323938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Functional%20assays%20for%20analysis%20of%20variants%20of%20uncertain%20significance%20in%20BRCA2&amp;author=L.%20Guidugli&amp;author=A.%20Carreira&amp;author=S.M.%20Caputo&amp;author=A.%20Ehlen&amp;author=A.%20Galli&amp;volume=35&amp;publication_year=2014&amp;pages=151-164&amp;pmid=24323938&amp;doi=10.1002/humu.22478&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24-ijms-22-07693">
<span class="label">24.</span><cite>Jhuraney A., Velkova A., Johnson R.C., Kessing B., Carvalho R.S., Whiley P., Spurdle A.B., Vreeswijk M.P.G., Caputo S.M., Millot G.A., et al.  BRCA1 Circos: A visualisation resource for functional analysis of missense variants. J. Med. Genet. 2015;52:224–230. doi: 10.1136/jmedgenet-2014-102766.</cite> [<a href="https://doi.org/10.1136/jmedgenet-2014-102766" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4392196/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25643705/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Genet.&amp;title=BRCA1%20Circos:%20A%20visualisation%20resource%20for%20functional%20analysis%20of%20missense%20variants&amp;author=A.%20Jhuraney&amp;author=A.%20Velkova&amp;author=R.C.%20Johnson&amp;author=B.%20Kessing&amp;author=R.S.%20Carvalho&amp;volume=52&amp;publication_year=2015&amp;pages=224-230&amp;pmid=25643705&amp;doi=10.1136/jmedgenet-2014-102766&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25-ijms-22-07693">
<span class="label">25.</span><cite>Lindor N.M., Guidugli L., Wang X., Vallée M.P., Monteiro A.N.A., Tavtigian S., Goldgar D.E., Couch F.J. A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS) Hum. Mutat. 2012;33:8–21. doi: 10.1002/humu.21627.</cite> [<a href="https://doi.org/10.1002/humu.21627" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3242438/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21990134/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=A%20review%20of%20a%20multifactorial%20probability-based%20model%20for%20classification%20of%20BRCA1%20and%20BRCA2%20variants%20of%20uncertain%20significance%20(VUS)&amp;author=N.M.%20Lindor&amp;author=L.%20Guidugli&amp;author=X.%20Wang&amp;author=M.P.%20Vall%C3%A9e&amp;author=A.N.A.%20Monteiro&amp;volume=33&amp;publication_year=2012&amp;pages=8-21&amp;pmid=21990134&amp;doi=10.1002/humu.21627&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26-ijms-22-07693">
<span class="label">26.</span><cite>Wardrop S.L., kConFab Investigators. Browna M.A. Identification of two evolutionarily conserved and functional regulatory elements in intron 2 of the human BRCA1 gene. Genomics. 2005;86:316–328. doi: 10.1016/j.ygeno.2005.05.006.</cite> [<a href="https://doi.org/10.1016/j.ygeno.2005.05.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15990270/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genomics&amp;title=Identification%20of%20two%20evolutionarily%20conserved%20and%20functional%20regulatory%20elements%20in%20intron%202%20of%20the%20human%20BRCA1%20gene&amp;author=S.L.%20Wardrop&amp;author=M.A.%20Browna&amp;volume=86&amp;publication_year=2005&amp;pages=316-328&amp;pmid=15990270&amp;doi=10.1016/j.ygeno.2005.05.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27-ijms-22-07693">
<span class="label">27.</span><cite>Breast Cancer Association Consortium. Dorling L., Carvalho S., Allen J., González-Neira A., Luccarini C., Wahlström C., Pooley K.A., Parsons M.T., Fortuno C., et al.  Breast Cancer Risk Genes-Association Analysis in More than 113,000 Women. N. Engl. J. Med. 2021;384:428–439. doi: 10.1056/NEJMoa1913948.</cite> [<a href="https://doi.org/10.1056/NEJMoa1913948" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7611105/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33471991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Breast%20Cancer%20Risk%20Genes-Association%20Analysis%20in%20More%20than%20113,000%20Women&amp;author=L.%20Dorling&amp;author=S.%20Carvalho&amp;author=J.%20Allen&amp;author=A.%20Gonz%C3%A1lez-Neira&amp;author=C.%20Luccarini&amp;volume=384&amp;publication_year=2021&amp;pages=428-439&amp;pmid=33471991&amp;doi=10.1056/NEJMoa1913948&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28-ijms-22-07693">
<span class="label">28.</span><cite>Couch F.J., Shimelis H., Hu C., Hart S.N., Polley E.C., Na J., Hallberg E., Moore R., Thomas A., Lilyquist J., et al.  Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer. JAMA Oncol. 2017;3:1190–1196. doi: 10.1001/jamaoncol.2017.0424.</cite> [<a href="https://doi.org/10.1001/jamaoncol.2017.0424" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5599323/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28418444/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncol.&amp;title=Associations%20Between%20Cancer%20Predisposition%20Testing%20Panel%20Genes%20and%20Breast%20Cancer&amp;author=F.J.%20Couch&amp;author=H.%20Shimelis&amp;author=C.%20Hu&amp;author=S.N.%20Hart&amp;author=E.C.%20Polley&amp;volume=3&amp;publication_year=2017&amp;pages=1190-1196&amp;pmid=28418444&amp;doi=10.1001/jamaoncol.2017.0424&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29-ijms-22-07693">
<span class="label">29.</span><cite>Hauke J., Horvath J., Groß E., Gehrig A., Honisch E., Hackmann K., Schmidt G., Arnold N., Faust U., Sutter C., et al.  Gene panel testing of 5589 BRCA1/2-negative index patientswith breast cancer in a routine diagnostic setting: Results ofthe German Consortium for Hereditary Breast and OvarianCancer. Cancer Med. 2018;7:1349–1358. doi: 10.1002/cam4.1376.</cite> [<a href="https://doi.org/10.1002/cam4.1376" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5911592/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29522266/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Med.&amp;title=Gene%20panel%20testing%20of%205589%20BRCA1/2-negative%20index%20patientswith%20breast%20cancer%20in%20a%20routine%20diagnostic%20setting:%20Results%20ofthe%20German%20Consortium%20for%20Hereditary%20Breast%20and%20OvarianCancer&amp;author=J.%20Hauke&amp;author=J.%20Horvath&amp;author=E.%20Gro%C3%9F&amp;author=A.%20Gehrig&amp;author=E.%20Honisch&amp;volume=7&amp;publication_year=2018&amp;pages=1349-1358&amp;pmid=29522266&amp;doi=10.1002/cam4.1376&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30-ijms-22-07693">
<span class="label">30.</span><cite>Buys S.S., Sandbach J.F., Gammon A., Patel G., Kidd G., Brown K.L., Sharma L., Saam J., Lancaster J., Daly M.B. A Study of Over 35,000 Women With Breast Cancer Tested With a 25-Gene Panel of Hereditary Cancer Genes. Cancer. 2017;123:1721–1730. doi: 10.1002/cncr.30498.</cite> [<a href="https://doi.org/10.1002/cncr.30498" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28085182/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=A%20Study%20of%20Over%2035,000%20Women%20With%20Breast%20Cancer%20Tested%20With%20a%2025-Gene%20Panel%20of%20Hereditary%20Cancer%20Genes&amp;author=S.S.%20Buys&amp;author=J.F.%20Sandbach&amp;author=A.%20Gammon&amp;author=G.%20Patel&amp;author=G.%20Kidd&amp;volume=123&amp;publication_year=2017&amp;pages=1721-1730&amp;pmid=28085182&amp;doi=10.1002/cncr.30498&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31-ijms-22-07693">
<span class="label">31.</span><cite>Santana Dos Santos E., Caputo S.M., Castera L., Gendrot M., Briaux A., Breault M., Krieger S., Rogan P.K., Mucaki E.J., Burke L.J., et al.  Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition. Breast Cancer Res. Treat. 2018;168:311–325. doi: 10.1007/s10549-017-4602-0.</cite> [<a href="https://doi.org/10.1007/s10549-017-4602-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29236234/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=Assessment%20of%20the%20functional%20impact%20of%20germline%20BRCA1/2%20variants%20located%20in%20non-coding%20regions%20in%20families%20with%20breast%20and/or%20ovarian%20cancer%20predisposition&amp;author=E.%20Santana%20Dos%20Santos&amp;author=S.M.%20Caputo&amp;author=L.%20Castera&amp;author=M.%20Gendrot&amp;author=A.%20Briaux&amp;volume=168&amp;publication_year=2018&amp;pages=311-325&amp;pmid=29236234&amp;doi=10.1007/s10549-017-4602-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32-ijms-22-07693">
<span class="label">32.</span><cite>Evans D.G.R., van Veen E.M., Byers H.J., Wallace A.J., Ellingford J., Beaman G.M., Santoyo-Lopez J., Aitman T.J., Eccles D., Lalloo F., et al.  A Dominantly Inherited 5’ UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer. Am. J. Hum. Genet. 2018;103:213–220. doi: 10.1016/j.ajhg.2018.07.002.</cite> [<a href="https://doi.org/10.1016/j.ajhg.2018.07.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6080768/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30075112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=A%20Dominantly%20Inherited%205%E2%80%99%20UTR%20Variant%20Causing%20Methylation-Associated%20Silencing%20of%20BRCA1%20as%20a%20Cause%20of%20Breast%20and%20Ovarian%20Cancer&amp;author=D.G.R.%20Evans&amp;author=E.M.%20van%20Veen&amp;author=H.J.%20Byers&amp;author=A.J.%20Wallace&amp;author=J.%20Ellingford&amp;volume=103&amp;publication_year=2018&amp;pages=213-220&amp;pmid=30075112&amp;doi=10.1016/j.ajhg.2018.07.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33-ijms-22-07693">
<span class="label">33.</span><cite>Laner A., Benet-Pages A., Neitzel B., Holinski-Feder E. Analysis of 3297 individuals suggests that the pathogenic germline 5’-UTR variant BRCA1 c.-107A &gt; T is not common in south-east Germany. Fam. Cancer. 2020;19:211–213. doi: 10.1007/s10689-020-00175-4.</cite> [<a href="https://doi.org/10.1007/s10689-020-00175-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32200540/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fam.%20Cancer&amp;title=Analysis%20of%203297%20individuals%20suggests%20that%20the%20pathogenic%20germline%205%E2%80%99-UTR%20variant%20BRCA1%20c.-107A%20&gt;%20T%20is%20not%20common%20in%20south-east%20Germany&amp;author=A.%20Laner&amp;author=A.%20Benet-Pages&amp;author=B.%20Neitzel&amp;author=E.%20Holinski-Feder&amp;volume=19&amp;publication_year=2020&amp;pages=211-213&amp;pmid=32200540&amp;doi=10.1007/s10689-020-00175-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34-ijms-22-07693">
<span class="label">34.</span><cite>Yoshikawa Y., Kozuma H., Morimatsu M., Sugawara K., Orino K. Reduced translation efficiency due to novel splicing variants in 5’ untranslated region and identification of novel cis-regulatory elements in canine and human BRCA2. BMC Mol. Cell Biol. 2021;22:2.  doi: 10.1186/s12860-020-00336-4.</cite> [<a href="https://doi.org/10.1186/s12860-020-00336-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7788759/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33407082/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Mol.%20Cell%20Biol.&amp;title=Reduced%20translation%20efficiency%20due%20to%20novel%20splicing%20variants%20in%205%E2%80%99%20untranslated%20region%20and%20identification%20of%20novel%20cis-regulatory%20elements%20in%20canine%20and%20human%20BRCA2&amp;author=Y.%20Yoshikawa&amp;author=H.%20Kozuma&amp;author=M.%20Morimatsu&amp;author=K.%20Sugawara&amp;author=K.%20Orino&amp;volume=22&amp;publication_year=2021&amp;pages=2&amp;pmid=33407082&amp;doi=10.1186/s12860-020-00336-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35-ijms-22-07693">
<span class="label">35.</span><cite>Montalban G., Bonache S., Moles-Fernández A., Gisbert-Beamud A., Tenés A., Bach V., Carrasco E., López-Fernández A., Stjepanovic N., Balmaña J., et al.  Screening of BRCA1/2 deep intronic regions by targeted gene sequencing identifies the first germline BRCA1 variant causing pseudoexon activation in a patient with breast/ovarian cancer. J. Med. Genet. 2019;56:63–74. doi: 10.1136/jmedgenet-2018-105606.</cite> [<a href="https://doi.org/10.1136/jmedgenet-2018-105606" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30472649/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Genet.&amp;title=Screening%20of%20BRCA1/2%20deep%20intronic%20regions%20by%20targeted%20gene%20sequencing%20identifies%20the%20first%20germline%20BRCA1%20variant%20causing%20pseudoexon%20activation%20in%20a%20patient%20with%20breast/ovarian%20cancer&amp;author=G.%20Montalban&amp;author=S.%20Bonache&amp;author=A.%20Moles-Fern%C3%A1ndez&amp;author=A.%20Gisbert-Beamud&amp;author=A.%20Ten%C3%A9s&amp;volume=56&amp;publication_year=2019&amp;pages=63-74&amp;pmid=30472649&amp;doi=10.1136/jmedgenet-2018-105606&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36-ijms-22-07693">
<span class="label">36.</span><cite>Shimelis H., LaDuca H., Hu C., Hart S.N., Na J., Thomas A., Akinhanmi M., Moore R., Brauch H., Cox A., et al.  Triple-Negative Breast Cancer Risk Genes Identified byMultigene Hereditary Cancer Panel Testing. J. Natl. Cancer Inst. 2018;110:855–862. doi: 10.1093/jnci/djy106.</cite> [<a href="https://doi.org/10.1093/jnci/djy106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6093350/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30099541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Natl.%20Cancer%20Inst.&amp;title=Triple-Negative%20Breast%20Cancer%20Risk%20Genes%20Identified%20byMultigene%20Hereditary%20Cancer%20Panel%20Testing&amp;author=H.%20Shimelis&amp;author=H.%20LaDuca&amp;author=C.%20Hu&amp;author=S.N.%20Hart&amp;author=J.%20Na&amp;volume=110&amp;publication_year=2018&amp;pages=855-862&amp;pmid=30099541&amp;doi=10.1093/jnci/djy106&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37-ijms-22-07693">
<span class="label">37.</span><cite>Zanti M., Loizidou M.A., Michailidou K., Pirpa P., Machattou C., Marcou Y., Kyriakou F., Kakouri E., Tanteles G.A., Spanou E., et al.  NGS Panel Testing of Triple-Negative Breast Cancer Patients in Cyprus: A Study of BRCA-Negative Cases. Cancers. 2020;12:3140.  doi: 10.3390/cancers12113140.</cite> [<a href="https://doi.org/10.3390/cancers12113140" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7692082/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33120919/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=NGS%20Panel%20Testing%20of%20Triple-Negative%20Breast%20Cancer%20Patients%20in%20Cyprus:%20A%20Study%20of%20BRCA-Negative%20Cases&amp;author=M.%20Zanti&amp;author=M.A.%20Loizidou&amp;author=K.%20Michailidou&amp;author=P.%20Pirpa&amp;author=C.%20Machattou&amp;volume=12&amp;publication_year=2020&amp;pages=3140&amp;pmid=33120919&amp;doi=10.3390/cancers12113140&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38-ijms-22-07693">
<span class="label">38.</span><cite>Spugnesi L., Gabriele M., Scarpitta R., Tancredi M., Maresca L., Gambino G., Collavoli A., Aretini P., Bertolini I., Salvadori B., et al.  Germline mutations in DNA repair genes may predict neoadjuvant therapy response in triple negative breast patients. Genes Chromosom. Cancer. 2016;55:915–924. doi: 10.1002/gcc.22389.</cite> [<a href="https://doi.org/10.1002/gcc.22389" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27328445/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes%20Chromosom.%20Cancer&amp;title=Germline%20mutations%20in%20DNA%20repair%20genes%20may%20predict%20neoadjuvant%20therapy%20response%20in%20triple%20negative%20breast%20patients&amp;author=L.%20Spugnesi&amp;author=M.%20Gabriele&amp;author=R.%20Scarpitta&amp;author=M.%20Tancredi&amp;author=L.%20Maresca&amp;volume=55&amp;publication_year=2016&amp;pages=915-924&amp;pmid=27328445&amp;doi=10.1002/gcc.22389&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39-ijms-22-07693">
<span class="label">39.</span><cite>Silver D.P., Richardson A.L., Eklund A.C., Wang Z.C., Szallasi Z., Li Q., Juul N., Leong C.-O., Calogrias D., Buraimoh A., et al.  Efficacy of neoadjuvant cisplatin in triple-negative breast cancer. J. Clin. Oncol. 2010;28:1145–1153. doi: 10.1200/JCO.2009.22.4725.</cite> [<a href="https://doi.org/10.1200/JCO.2009.22.4725" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2834466/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20100965/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Oncol.&amp;title=Efficacy%20of%20neoadjuvant%20cisplatin%20in%20triple-negative%20breast%20cancer&amp;author=D.P.%20Silver&amp;author=A.L.%20Richardson&amp;author=A.C.%20Eklund&amp;author=Z.C.%20Wang&amp;author=Z.%20Szallasi&amp;volume=28&amp;publication_year=2010&amp;pages=1145-1153&amp;pmid=20100965&amp;doi=10.1200/JCO.2009.22.4725&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40-ijms-22-07693">
<span class="label">40.</span><cite>Byrski T., Dent R., Blecharz P., Foszczynska-Kloda M., Gronwald J., Huzarski T., Cybulski C., Marczyk E., Chrzan R., Eisen A., et al.  Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer. Breast Cancer Res. 2012;14:R110. doi: 10.1186/bcr3231.</cite> [<a href="https://doi.org/10.1186/bcr3231" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3680929/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22817698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.&amp;title=Results%20of%20a%20phase%20II%20open-label,%20non-randomized%20trial%20of%20cisplatin%20chemotherapy%20in%20patients%20with%20BRCA1-positive%20metastatic%20breast%20cancer&amp;author=T.%20Byrski&amp;author=R.%20Dent&amp;author=P.%20Blecharz&amp;author=M.%20Foszczynska-Kloda&amp;author=J.%20Gronwald&amp;volume=14&amp;publication_year=2012&amp;pages=R110&amp;pmid=22817698&amp;doi=10.1186/bcr3231&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41-ijms-22-07693">
<span class="label">41.</span><cite>Priyanka S. Biology and Management of Patients With Triple-Negative Breast Cancer. Oncologist. 2016;21:1050–1062. doi: 10.1634/theoncologist.2016-0067.</cite> [<a href="https://doi.org/10.1634/theoncologist.2016-0067" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5016071/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27401886/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncologist&amp;title=Biology%20and%20Management%20of%20Patients%20With%20Triple-Negative%20Breast%20Cancer&amp;author=S.%20Priyanka&amp;volume=21&amp;publication_year=2016&amp;pages=1050-1062&amp;pmid=27401886&amp;doi=10.1634/theoncologist.2016-0067&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42-ijms-22-07693">
<span class="label">42.</span><cite>Lu H.-M., Li S., Black M.H., Lee S., Hoiness R., Wu S., Mu W., Huether R., Chen J., Sridhar S., et al.  Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing. JAMA Oncol. 2019;5:122. doi: 10.1001/jamaoncol.2018.2956.</cite> [<a href="https://doi.org/10.1001/jamaoncol.2018.2956" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6439764/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30128536/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncol.&amp;title=Association%20of%20Breast%20and%20Ovarian%20Cancers%20With%20Predisposition%20Genes%20Identified%20by%20Large-Scale%20Sequencing&amp;author=H.-M.%20Lu&amp;author=S.%20Li&amp;author=M.H.%20Black&amp;author=S.%20Lee&amp;author=R.%20Hoiness&amp;volume=5&amp;publication_year=2019&amp;pages=122&amp;pmid=30128536&amp;doi=10.1001/jamaoncol.2018.2956&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43-ijms-22-07693">
<span class="label">43.</span><cite>Cooper G.M., Stone E.A., Asimenos G., NISC Comparative Sequencing Program. Green E.D., Batzoglou S. Arend Sidow Distribution and intensity of constraint in mammalian genomic sequence. Genome Res. 2005;15:901–913. doi: 10.1101/gr.3577405.</cite> [<a href="https://doi.org/10.1101/gr.3577405" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1172034/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15965027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Res.&amp;title=Arend%20Sidow%20Distribution%20and%20intensity%20of%20constraint%20in%20mammalian%20genomic%20sequence&amp;author=G.M.%20Cooper&amp;author=E.A.%20Stone&amp;author=G.%20Asimenos&amp;author=E.D.%20Green&amp;author=S.%20Batzoglou&amp;volume=15&amp;publication_year=2005&amp;pages=901-913&amp;pmid=15965027&amp;doi=10.1101/gr.3577405&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44-ijms-22-07693">
<span class="label">44.</span><cite>Landrum M.J., Lee J.M., Benson M., Brown G., Chao C., Chitipiralla S., Gu B., Hart J., Hoffman D., Hoover J., et al.  ClinVar: Public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2016;44:D862–D868. doi: 10.1093/nar/gkv1222.</cite> [<a href="https://doi.org/10.1093/nar/gkv1222" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4702865/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26582918/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=ClinVar:%20Public%20archive%20of%20interpretations%20of%20clinically%20relevant%20variants&amp;author=M.J.%20Landrum&amp;author=J.M.%20Lee&amp;author=M.%20Benson&amp;author=G.%20Brown&amp;author=C.%20Chao&amp;volume=44&amp;publication_year=2016&amp;pages=D862-D868&amp;pmid=26582918&amp;doi=10.1093/nar/gkv1222&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45-ijms-22-07693">
<span class="label">45.</span><cite>Maxwell K.N., Hart S.N., Vijai J., Schrader K.A., Slavin T.P., Thomas T., Wubbenhorst B., Ravichandran V., Moore R.M., Hu C., et al.  Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer. Am. J. Hum. Genet. 2016;98:801–817. doi: 10.1016/j.ajhg.2016.02.024.</cite> [<a href="https://doi.org/10.1016/j.ajhg.2016.02.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4863474/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27153395/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=Evaluation%20of%20ACMG-Guideline-Based%20Variant%20Classification%20of%20Cancer%20Susceptibility%20and%20Non-Cancer-Associated%20Genes%20in%20Families%20Affected%20by%20Breast%20Cancer&amp;author=K.N.%20Maxwell&amp;author=S.N.%20Hart&amp;author=J.%20Vijai&amp;author=K.A.%20Schrader&amp;author=T.P.%20Slavin&amp;volume=98&amp;publication_year=2016&amp;pages=801-817&amp;pmid=27153395&amp;doi=10.1016/j.ajhg.2016.02.024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46-ijms-22-07693">
<span class="label">46.</span><cite>Kopanos C., Tsiolkas V., Kouris A., Chapple C.E., Aguilera M.A., Meyer R., Massouras A. VarSome: The human genomic variant search engine. Bioinformatics. 2019;35:1978–1980. doi: 10.1093/bioinformatics/bty897.</cite> [<a href="https://doi.org/10.1093/bioinformatics/bty897" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6546127/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30376034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=VarSome:%20The%20human%20genomic%20variant%20search%20engine&amp;author=C.%20Kopanos&amp;author=V.%20Tsiolkas&amp;author=A.%20Kouris&amp;author=C.E.%20Chapple&amp;author=M.A.%20Aguilera&amp;volume=35&amp;publication_year=2019&amp;pages=1978-1980&amp;pmid=30376034&amp;doi=10.1093/bioinformatics/bty897&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47-ijms-22-07693">
<span class="label">47.</span><cite>Adzhubei I., Jordan D.M., Sunyaev S.R. Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. 2013 doi: 10.1002/0471142905.hg0720s76.</cite> [<a href="https://doi.org/10.1002/0471142905.hg0720s76" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4480630/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23315928/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Protoc.%20Hum.%20Genet.&amp;title=Predicting%20functional%20effect%20of%20human%20missense%20mutations%20using%20PolyPhen-2&amp;author=I.%20Adzhubei&amp;author=D.M.%20Jordan&amp;author=S.R.%20Sunyaev&amp;publication_year=2013&amp;pmid=23315928&amp;doi=10.1002/0471142905.hg0720s76&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48-ijms-22-07693">
<span class="label">48.</span><cite>Choi Y., Chan A.P. PROVEAN web server: A tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31:2745–2747. doi: 10.1093/bioinformatics/btv195.</cite> [<a href="https://doi.org/10.1093/bioinformatics/btv195" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4528627/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25851949/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=PROVEAN%20web%20server:%20A%20tool%20to%20predict%20the%20functional%20effect%20of%20amino%20acid%20substitutions%20and%20indels&amp;author=Y.%20Choi&amp;author=A.P.%20Chan&amp;volume=31&amp;publication_year=2015&amp;pages=2745-2747&amp;pmid=25851949&amp;doi=10.1093/bioinformatics/btv195&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B49-ijms-22-07693">
<span class="label">49.</span><cite>Guo L., Du Y., Qu S., Wang J. rVarBase: An updated database for regulatory features of human variants. Nucleic Acids Res. 2016;44:D888–D893. doi: 10.1093/nar/gkv1107.</cite> [<a href="https://doi.org/10.1093/nar/gkv1107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4702808/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26503253/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=rVarBase:%20An%20updated%20database%20for%20regulatory%20features%20of%20human%20variants&amp;author=L.%20Guo&amp;author=Y.%20Du&amp;author=S.%20Qu&amp;author=J.%20Wang&amp;volume=44&amp;publication_year=2016&amp;pages=D888-D893&amp;pmid=26503253&amp;doi=10.1093/nar/gkv1107&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B50-ijms-22-07693">
<span class="label">50.</span><cite>Ward L.D., Kellis M. Interpreting noncoding genetic variation in complex traits and human disease. Nat. Biotechnol. 2012;30:1095–1106. doi: 10.1038/nbt.2422.</cite> [<a href="https://doi.org/10.1038/nbt.2422" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3703467/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23138309/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Biotechnol.&amp;title=Interpreting%20noncoding%20genetic%20variation%20in%20complex%20traits%20and%20human%20disease&amp;author=L.D.%20Ward&amp;author=M.%20Kellis&amp;volume=30&amp;publication_year=2012&amp;pages=1095-1106&amp;pmid=23138309&amp;doi=10.1038/nbt.2422&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B51-ijms-22-07693">
<span class="label">51.</span><cite>Rojano E., Seoane P., Ranea JA G., Perkins J.R. Regulatory variants: From detection to predicting impact. Brief Bioinform. 2018;20:1639–1654. doi: 10.1093/bib/bby039.</cite> [<a href="https://doi.org/10.1093/bib/bby039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6917219/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29893792/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brief%20Bioinform.&amp;title=Regulatory%20variants:%20From%20detection%20to%20predicting%20impact&amp;author=E.%20Rojano&amp;author=P.%20Seoane&amp;author=G.%20Ranea%20JA&amp;author=J.R.%20Perkins&amp;volume=20&amp;publication_year=2018&amp;pages=1639-1654&amp;pmid=29893792&amp;doi=10.1093/bib/bby039&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B52-ijms-22-07693">
<span class="label">52.</span><cite>Farré D., Roset R., Huerta M., Adsuara J.E., Roselló L., Albà M.M., Messeguer X. Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 2003;31:3651–3653. doi: 10.1093/nar/gkg605.</cite> [<a href="https://doi.org/10.1093/nar/gkg605" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC169011/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12824386/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=Identification%20of%20patterns%20in%20biological%20sequences%20at%20the%20ALGGEN%20server:%20PROMO%20and%20MALGEN&amp;author=D.%20Farr%C3%A9&amp;author=R.%20Roset&amp;author=M.%20Huerta&amp;author=J.E.%20Adsuara&amp;author=L.%20Rosell%C3%B3&amp;volume=31&amp;publication_year=2003&amp;pages=3651-3653&amp;pmid=12824386&amp;doi=10.1093/nar/gkg605&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B53-ijms-22-07693">
<span class="label">53.</span><cite>Lee C., Huang C.H. LASAGNA-Search 2.0: Integrated transcription factor binding site search and visualization in a browser. Bioinformatics. 2014;30:1923–1925. doi: 10.1093/bioinformatics/btu115.</cite> [<a href="https://doi.org/10.1093/bioinformatics/btu115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24578403/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=LASAGNA-Search%202.0:%20Integrated%20transcription%20factor%20binding%20site%20search%20and%20visualization%20in%20a%20browser&amp;author=C.%20Lee&amp;author=C.H.%20Huang&amp;volume=30&amp;publication_year=2014&amp;pages=1923-1925&amp;pmid=24578403&amp;doi=10.1093/bioinformatics/btu115&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B54-ijms-22-07693">
<span class="label">54.</span><cite>Agarwal V., Bell G.W., Nam J., Bartel D.P. Predicting effective microRNA target sites in mammalian mRNAs. eLife. 2015;4:e05005. doi: 10.7554/eLife.05005.</cite> [<a href="https://doi.org/10.7554/eLife.05005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4532895/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26267216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=eLife&amp;title=Predicting%20effective%20microRNA%20target%20sites%20in%20mammalian%20mRNAs&amp;author=V.%20Agarwal&amp;author=G.W.%20Bell&amp;author=J.%20Nam&amp;author=D.P.%20Bartel&amp;volume=4&amp;publication_year=2015&amp;pages=e05005&amp;pmid=26267216&amp;doi=10.7554/eLife.05005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B55-ijms-22-07693">
<span class="label">55.</span><cite>Yuhao C., Xiaowei W. miRDB: An online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48:D127–D131. doi: 10.1093/nar/gkz757.</cite> [<a href="https://doi.org/10.1093/nar/gkz757" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6943051/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31504780/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=miRDB:%20An%20online%20database%20for%20prediction%20of%20functional%20microRNA%20targets&amp;author=C.%20Yuhao&amp;author=W.%20Xiaowei&amp;volume=48&amp;publication_year=2020&amp;pages=D127-D131&amp;pmid=31504780&amp;doi=10.1093/nar/gkz757&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B56-ijms-22-07693">
<span class="label">56.</span><cite>Ohno K., Takeda J.I., Masuda A. Rules and tools to predict the splicing effects of exonic and intronic mutations. Wiley Interdiscip. Rev. RNA. 2018;9 doi: 10.1002/wrna.1451.</cite> [<a href="https://doi.org/10.1002/wrna.1451" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28949076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Wiley%20Interdiscip.%20Rev.%20RNA&amp;title=Rules%20and%20tools%20to%20predict%20the%20splicing%20effects%20of%20exonic%20and%20intronic%20mutations&amp;author=K.%20Ohno&amp;author=J.I.%20Takeda&amp;author=A.%20Masuda&amp;volume=9&amp;publication_year=2018&amp;pmid=28949076&amp;doi=10.1002/wrna.1451&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/8305371/bin/ijms-22-07693-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (248.5KB, zip) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from International Journal of Molecular Sciences are provided here courtesy of <strong>Multidisciplinary Digital Publishing Institute  (MDPI)</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3390/ijms22147693"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/ijms-22-07693.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.0 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/8305371/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/8305371/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8305371%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8305371/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC8305371/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC8305371/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/34299313/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC8305371/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/34299313/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC8305371/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/8305371/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="T1saAC3V3jvLdAqxgRH8HhutzS4kd5K2vbSnmuwtk1Z5oGVywQ5Iepn9GKtxgQfx">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
